/*
 Navicat Premium Data Transfer

 Source Server         : local@aric
 Source Server Type    : MySQL
 Source Server Version : 50736
 Source Host           : localhost:3306
 Source Schema         : curator_development

 Target Server Type    : MySQL
 Target Server Version : 50736
 File Encoding         : 65001

 Date: 15/12/2021 14:46:17
*/

SET NAMES utf8mb4;
SET FOREIGN_KEY_CHECKS = 0;

-- ----------------------------
-- Table structure for annotations
-- ----------------------------
DROP TABLE IF EXISTS `annotations`;
CREATE TABLE `annotations` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `atype` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `atext` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `passage_id` int(11) DEFAULT NULL,
  `sentence_id` int(11) DEFAULT NULL,
  `aid` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `document_id` int(11) DEFAULT NULL,
  `locations_count` int(11) DEFAULT '0',
  `entity_key` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `entity_type_id` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `index_annotations_on_entity_type_id` (`entity_type_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of annotations
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for collections
-- ----------------------------
DROP TABLE IF EXISTS `collections`;
CREATE TABLE `collections` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `source` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `key` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `s_date` date DEFAULT NULL,
  `owner_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `documents_count` int(11) DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `index_collections_on_owner_id` (`owner_id`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of collections
-- ----------------------------
BEGIN;
INSERT INTO `collections` VALUES (1, 'test', '', '', '2021-11-30', 1, '2021-11-30 07:31:24', '2021-11-30 07:31:24', 6);
COMMIT;

-- ----------------------------
-- Table structure for document_caches
-- ----------------------------
DROP TABLE IF EXISTS `document_caches`;
CREATE TABLE `document_caches` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `source` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `abstract` text COLLATE utf8_unicode_ci,
  `authors` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `year` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `title` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `au` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `medline` text COLLATE utf8_unicode_ci,
  `pmid` int(11) DEFAULT NULL,
  `ppi_score` float DEFAULT NULL,
  `pubdate` date DEFAULT NULL,
  `update_date` date DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=33896729 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of document_caches
-- ----------------------------
BEGIN;
INSERT INTO `document_caches` VALUES (10222154, 'Exp Cell Res. 1999 May 1. 248(2):620-6', 'A novel human cDNA sequence has been isolated from human testis cDNA library. This sequence, named PD1, reveals an open reading frame encoding a protein of 520 amino acids. A partial sequence similarity has been found with the RBM gene involved in the regulation of human spermatogenesis. Northern blot analysis for PD1 mRNA from several human tissues demonstrated two distinct transcripts of 2.7 (more abundant) and 4.0 kb and revealed that PD1 is expressed in testis and to a lesser extent also in spleen, thymus, and prostate. Immunohistochemical analysis of human testis showed that this protein is detected in the cytoplasm of Sertoli cells. Antibodies against a rhPD1 fragment were used for Western blot analysis, which confirmed the presence of a 60-kDa molecule in crude extract of human testicular cells obtained from fine-needle aspiration and showed different patterns in various testiculopathies, suggesting a role for such gene in human spermatogenesis.', NULL, '1999', 'cDNA cloning and characterization of PD1: a novel human testicular protein with different expressions in various testiculopathies.', '2021-11-30 07:45:02', '2021-11-30 07:45:02', 'Graziotto R, Foresta C, Scannapieco P, Zeilante P, Russo A, Negro A, Salmaso R, Onisto M', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">10222154</PMID><DateCompleted><Year>1999</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">0014-4827</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>248</Volume><Issue>2</Issue><PubDate><Year>1999</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Experimental cell research</Title><ISOAbbreviation>Exp Cell Res</ISOAbbreviation></Journal><ArticleTitle>cDNA cloning and characterization of PD1: a novel human testicular protein with different expressions in various testiculopathies.</ArticleTitle><Pagination><MedlinePgn>620-6</MedlinePgn></Pagination><Abstract><AbstractText>A novel human cDNA sequence has been isolated from human testis cDNA library. This sequence, named PD1, reveals an open reading frame encoding a protein of 520 amino acids. A partial sequence similarity has been found with the RBM gene involved in the regulation of human spermatogenesis. Northern blot analysis for PD1 mRNA from several human tissues demonstrated two distinct transcripts of 2.7 (more abundant) and 4.0 kb and revealed that PD1 is expressed in testis and to a lesser extent also in spleen, thymus, and prostate. Immunohistochemical analysis of human testis showed that this protein is detected in the cytoplasm of Sertoli cells. Antibodies against a rhPD1 fragment were used for Western blot analysis, which confirmed the presence of a 60-kDa molecule in crude extract of human testicular cells obtained from fine-needle aspiration and showed different patterns in various testiculopathies, suggesting a role for such gene in human spermatogenesis.</AbstractText><CopyrightInformation>Copyright 1999 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Graziotto</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Histology and Embryology, Department of Biology, Department of Biochemistry, University of Padova, Viale G. Colombo 3, Padua, 35121, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Foresta</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN=\"Y\"><LastName>Scannapieco</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN=\"Y\"><LastName>Zeilante</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN=\"Y\"><LastName>Russo</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Negro</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Salmaso</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN=\"Y\"><LastName>Onisto</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>U28164</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Cell Res</MedlineTA><NlmUniqueID>0373226</NlmUniqueID><ISSNLinking>0014-4827</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018076\">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D009687\">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C501499\">RBMY1A1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016601\">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000595\" MajorTopicYN=\"N\">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001483\" MajorTopicYN=\"N\">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015152\" MajorTopicYN=\"N\">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015139\" MajorTopicYN=\"N\">Blotting, Southern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003001\" MajorTopicYN=\"N\">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018076\" MajorTopicYN=\"N\">DNA, Complementary</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008969\" MajorTopicYN=\"N\">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009687\" MajorTopicYN=\"N\">Nuclear Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName><QualifierName UI=\"Q000302\" MajorTopicYN=\"N\">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016601\" MajorTopicYN=\"N\">RNA-Binding Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012671\" MajorTopicYN=\"N\">Seminiferous Tubules</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017386\" MajorTopicYN=\"N\">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012708\" MajorTopicYN=\"N\">Sertoli Cells</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013076\" MajorTopicYN=\"N\">Sperm Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013091\" MajorTopicYN=\"N\">Spermatogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013737\" MajorTopicYN=\"N\">Testis</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"Y\">chemistry</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"Y\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014018\" MajorTopicYN=\"N\">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>1999</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>1999</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>1999</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">10222154</ArticleId><ArticleId IdType=\"pii\">S0014-4827(99)94449-X</ArticleId><ArticleId IdType=\"doi\">10.1006/excr.1999.4449</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 10222154, -0.0414, '1999-05-01', '2005-11-21');
INSERT INTO `document_caches` VALUES (11079456, 'J Endocrinol Invest. 2000 Oct. 23(9):605-8', 'PD1 is a novel protein particularly expressed at the testicular level. The relative cDNA sequences were cloned from human and rat testis libraries revealing an open reading frame for a protein of 520 and 511 amino acids respectively. The human PD1 amino acid sequence shows 85% identity with rat sequence suggesting that PD1 gene has been highly conserved during mammalian evolution. Immunohistochemical analysis showed that this protein is detected in the tubular compartment of the testis and, in particular, in the cytoplasm of the Sertoli cells. PD1 expression is not constitutive but seems to be under the influence of neighboring spermatogenic cells as demonstrated by its reduction in hypospermatogenesis with respect to normal spermatogenesis and a further reduction in Sertoli cell-only syndrome. During testicular development in the rat (from 2 to 45 days of age) the PD1 mRNA level became detectable at 14 days and then increased steadily with an advancement of age. These findings suggest that PD1 may play a role in the regulation of spermatogenesis and may be a potential candidate gene for defects of male fertility.', NULL, '2000', 'A novel gene (PD1) with a potential role on rat spermatogenesis.', '2021-11-30 07:45:08', '2021-11-30 07:45:08', 'Onisto M, Graziotto R, Scannapieco P, Marin P, Merico M, Slongo ML, Foresta C', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">11079456</PMID><DateCompleted><Year>2001</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">0391-4097</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>23</Volume><Issue>9</Issue><PubDate><Year>2000</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of endocrinological investigation</Title><ISOAbbreviation>J Endocrinol Invest</ISOAbbreviation></Journal><ArticleTitle>A novel gene (PD1) with a potential role on rat spermatogenesis.</ArticleTitle><Pagination><MedlinePgn>605-8</MedlinePgn></Pagination><Abstract><AbstractText>PD1 is a novel protein particularly expressed at the testicular level. The relative cDNA sequences were cloned from human and rat testis libraries revealing an open reading frame for a protein of 520 and 511 amino acids respectively. The human PD1 amino acid sequence shows 85% identity with rat sequence suggesting that PD1 gene has been highly conserved during mammalian evolution. Immunohistochemical analysis showed that this protein is detected in the tubular compartment of the testis and, in particular, in the cytoplasm of the Sertoli cells. PD1 expression is not constitutive but seems to be under the influence of neighboring spermatogenic cells as demonstrated by its reduction in hypospermatogenesis with respect to normal spermatogenesis and a further reduction in Sertoli cell-only syndrome. During testicular development in the rat (from 2 to 45 days of age) the PD1 mRNA level became detectable at 14 days and then increased steadily with an advancement of age. These findings suggest that PD1 may play a role in the regulation of spermatogenesis and may be a potential candidate gene for defects of male fertility.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Onisto</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Histology and Embryology, University of Padova, Italy. onisto@civ.bio.unipd.it</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Graziotto</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN=\"Y\"><LastName>Scannapieco</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN=\"Y\"><LastName>Marin</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN=\"Y\"><LastName>Merico</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN=\"Y\"><LastName>Slongo</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN=\"Y\"><LastName>Foresta</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>U28164</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI=\"D003160\">Comparative Study</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Endocrinol Invest</MedlineTA><NlmUniqueID>7806594</NlmUniqueID><ISSNLinking>0391-4097</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D012333\">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000595\" MajorTopicYN=\"N\">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008969\" MajorTopicYN=\"N\">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012333\" MajorTopicYN=\"N\">RNA, Messenger</DescriptorName><QualifierName UI=\"Q000032\" MajorTopicYN=\"N\">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051381\" MajorTopicYN=\"N\">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017385\" MajorTopicYN=\"N\">Sequence Homology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013091\" MajorTopicYN=\"N\">Spermatogenesis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013737\" MajorTopicYN=\"N\">Testis</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>11</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2000</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2001</Year><Month>3</Month><Day>3</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2000</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">11079456</ArticleId><ArticleId IdType=\"doi\">10.1007/BF03343783</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell. 1993 Dec 31;75(7):1287-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8269511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Endocrinol. 1988 Jul;58(1):51-63</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3145227</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Anat. 1957 Mar;100(2):241-67</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">13435229</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytogenet Cell Genet. 1998;81(1):65-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9691178</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Oct 24;278(5338):675-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9381176</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 1998 Jun;69(6):989-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9627280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Reprod. 1998 Feb;13(2):302-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9557827</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Cell Res. 1999 May 1;248(2):620-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10222154</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Endocrinol. 1990 Jul 30;72(1):13-22</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2177014</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1997 Sep 1;25(17):3389-402</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9254694</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytogenet Cell Genet. 1998;82(1-2):41-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9763657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 11079456, -0.1968, '2000-11-18', '2018-11-13');
INSERT INTO `document_caches` VALUES (11322771, 'Biochem Biophys Res Commun. 2001 Apr 27. 283(1):86-92', 'Here we report the cloning and characterization of a novel cDNA named spata 2. SPATA2 is the ortholog of PD1, a human testicular protein which has been suggested to play a role in spermatogenesis. The spata 2 sequence reveals an open reading frame encoding a protein of 511 amino acids. Northern blot analysis with rat mRNA demonstrated two distinct transcripts of 2.2 and 4.0 kb. Tagging recombinant SPATA2 with the green fluorescent protein (GFP) and expressing the chimeric polypeptide in HLtat transfected cells indicated that SPATA2 is located in the nucleus. RT-PCR analysis revealed that spata 2 mRNA is expressed in the testis and to a lesser extent in the brain while skeletal muscle and kidney showed a barely visible signal. The same analysis demonstrated that isolated Sertoli cells express spata 2 mRNA. Treating Sertoli cells with FSH in vitro induced remarkable changes in the steady-state level of spata 2 mRNA in a time-dependent manner. In developing testis spata 2 transcripts were first detected 10 days post partum and expression levels increased steadily with age. The ability of FSH to stimulate spata 2 mRNA expression as well as its developmental expression suggests that this protein might play a role in regulating spermatogenesis and thus, according to the Gene Nomenclature Committee, we propose the name SPATA2 (Spermatogenesis associated protein 2) for this protein (or gene).', NULL, '2001', 'Evidence for FSH-dependent upregulation of SPATA2 (spermatogenesis-associated protein 2).', '2021-11-30 07:44:59', '2021-11-30 07:44:59', 'Onisto M, Slongo LM, Graziotto R, Zotti L, Negro A, Merico M, Moro E, Foresta C, Maurizio O, Liliana SM, Romina G, Lorenza Z, Alessandro N, Maurizio M, Enrico M, Carlo F', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">11322771</PMID><DateCompleted><Year>2001</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">0006-291X</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>283</Volume><Issue>1</Issue><PubDate><Year>2001</Year><Month>Apr</Month><Day>27</Day></PubDate></JournalIssue><Title>Biochemical and biophysical research communications</Title><ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation></Journal><ArticleTitle>Evidence for FSH-dependent upregulation of SPATA2 (spermatogenesis-associated protein 2).</ArticleTitle><Pagination><MedlinePgn>86-92</MedlinePgn></Pagination><Abstract><AbstractText>Here we report the cloning and characterization of a novel cDNA named spata 2. SPATA2 is the ortholog of PD1, a human testicular protein which has been suggested to play a role in spermatogenesis. The spata 2 sequence reveals an open reading frame encoding a protein of 511 amino acids. Northern blot analysis with rat mRNA demonstrated two distinct transcripts of 2.2 and 4.0 kb. Tagging recombinant SPATA2 with the green fluorescent protein (GFP) and expressing the chimeric polypeptide in HLtat transfected cells indicated that SPATA2 is located in the nucleus. RT-PCR analysis revealed that spata 2 mRNA is expressed in the testis and to a lesser extent in the brain while skeletal muscle and kidney showed a barely visible signal. The same analysis demonstrated that isolated Sertoli cells express spata 2 mRNA. Treating Sertoli cells with FSH in vitro induced remarkable changes in the steady-state level of spata 2 mRNA in a time-dependent manner. In developing testis spata 2 transcripts were first detected 10 days post partum and expression levels increased steadily with age. The ability of FSH to stimulate spata 2 mRNA expression as well as its developmental expression suggests that this protein might play a role in regulating spermatogenesis and thus, according to the Gene Nomenclature Committee, we propose the name SPATA2 (Spermatogenesis associated protein 2) for this protein (or gene).</AbstractText><CopyrightInformation>Copyright 2001 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Onisto</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental Biomedical Sciences, University of Padova, Padua, 35121, Italy. onisto@civ.bio.unipd.it</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Slongo</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author ValidYN=\"Y\"><LastName>Graziotto</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN=\"Y\"><LastName>Zotti</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN=\"Y\"><LastName>Negro</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Merico</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN=\"Y\"><LastName>Moro</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN=\"Y\"><LastName>Foresta</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN=\"N\"><LastName>Maurizio</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN=\"N\"><LastName>Liliana</LastName><ForeName>S M</ForeName><Initials>SM</Initials></Author><Author ValidYN=\"N\"><LastName>Romina</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN=\"N\"><LastName>Lorenza</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Author><Author ValidYN=\"N\"><LastName>Alessandro</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN=\"N\"><LastName>Maurizio</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN=\"N\"><LastName>Enrico</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN=\"N\"><LastName>Carlo</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AF123651</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN=\"Y\"><Grant><GrantID>E.1065</GrantID><Agency>Telethon</Agency><Country>Italy</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008164\">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D012333\">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011993\">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI=\"D049452\">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-68-0</RegistryNumber><NameOfSubstance UI=\"D005640\">Follicle Stimulating Hormone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType=\"ErratumIn\"><RefSource>Biochem Biophys Res Commun 2001 Jul 13;285(2):570</RefSource><Note>Maurizio, O [corrected to Onisto, M]; Liliana, SM [corrected to Slongo, LM]; Romina, G [corrected to Graziotto, R], Lorenza, Z [corrected to Zotti, L]; Alessandro, N [corrected to Negro, A], Maurizio, M [corrected to Merico, M]; Enrico, M [corrected to Mor</Note></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000595\" MajorTopicYN=\"N\">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001483\" MajorTopicYN=\"N\">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002478\" MajorTopicYN=\"N\">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003001\" MajorTopicYN=\"N\">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005640\" MajorTopicYN=\"N\">Follicle Stimulating Hormone</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"Y\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018507\" MajorTopicYN=\"N\">Gene Expression Regulation, Developmental</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D049452\" MajorTopicYN=\"N\">Green Fluorescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008164\" MajorTopicYN=\"N\">Luminescent Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008969\" MajorTopicYN=\"N\">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009928\" MajorTopicYN=\"N\">Organ Specificity</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012333\" MajorTopicYN=\"N\">RNA, Messenger</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051381\" MajorTopicYN=\"N\">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017207\" MajorTopicYN=\"N\">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011993\" MajorTopicYN=\"N\">Recombinant Fusion Proteins</DescriptorName><QualifierName UI=\"Q000096\" MajorTopicYN=\"N\">biosynthesis</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013091\" MajorTopicYN=\"N\">Spermatogenesis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013737\" MajorTopicYN=\"N\">Testis</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2001</Year><Month>4</Month><Day>27</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2001</Year><Month>5</Month><Day>18</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2001</Year><Month>4</Month><Day>27</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">11322771</ArticleId><ArticleId IdType=\"doi\">10.1006/bbrc.2001.4754</ArticleId><ArticleId IdType=\"pii\">S0006291X01947540</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 11322771, 0.048, '2001-04-27', '2017-09-22');
INSERT INTO `document_caches` VALUES (12531478, 'Biochim Biophys Acta. 2003 Jan 27. 1625(2):192-6', 'In this paper, we report the genomic organization of the human spata2 (spermatogenesis-associated protein 2) gene and the characterization of its promoter region. The 5\'-flanking region lacks canonical TATA-box but contains a CAAT-box and potential binding sites for a variety of transcription factors such as Sp1, NF-1 and CREB. The results indicated that (1) the cis-acting elements necessary for a basal transcription of spata2 are contained within the -81/+159 proximal sequence of the promoter and (2) the strongest promoter activity was exhibited by the -403/+159 region that contains a CREB site.', NULL, '2003', 'Cloning and characterization of the promoter region of human spata2 (spermatogenesis-associated protein 2) gene.', '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'Liliana Slongo M, Zotti L, Onisto M', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">12531478</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">0006-3002</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>1625</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Biochimica et biophysica acta</Title><ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation></Journal><ArticleTitle>Cloning and characterization of the promoter region of human spata2 (spermatogenesis-associated protein 2) gene.</ArticleTitle><Pagination><MedlinePgn>192-6</MedlinePgn></Pagination><Abstract><AbstractText>In this paper, we report the genomic organization of the human spata2 (spermatogenesis-associated protein 2) gene and the characterization of its promoter region. The 5\'-flanking region lacks canonical TATA-box but contains a CAAT-box and potential binding sites for a variety of transcription factors such as Sp1, NF-1 and CREB. The results indicated that (1) the cis-acting elements necessary for a basal transcription of spata2 are contained within the -81/+159 proximal sequence of the promoter and (2) the strongest promoter activity was exhibited by the -403/+159 region that contains a CREB site.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Liliana Slongo</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental Biomedical Sciences, University of Padova, Viale G. Colombo 3, 35121 Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zotti</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials></Author><Author ValidYN=\"Y\"><LastName>Onisto</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D017362\">Cyclic AMP Response Element-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018076\">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001483\" MajorTopicYN=\"N\">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001665\" MajorTopicYN=\"N\">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002460\" MajorTopicYN=\"N\">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003001\" MajorTopicYN=\"N\">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017362\" MajorTopicYN=\"N\">Cyclic AMP Response Element-Binding Protein</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018076\" MajorTopicYN=\"N\">DNA, Complementary</DescriptorName><QualifierName UI=\"Q000096\" MajorTopicYN=\"N\">biosynthesis</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008969\" MajorTopicYN=\"N\">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011401\" MajorTopicYN=\"N\">Promoter Regions, Genetic</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000502\" MajorTopicYN=\"Y\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D024363\" MajorTopicYN=\"N\">Transcription Initiation Site</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2003</Year><Month>1</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2003</Year><Month>4</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2003</Year><Month>1</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">12531478</ArticleId><ArticleId IdType=\"pii\">S0167478102005948</ArticleId><ArticleId IdType=\"doi\">10.1016/s0167-4781(02)00594-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 12531478, -0.4147, '2003-01-18', '2019-06-10');
INSERT INTO `document_caches` VALUES (17486545, 'Int J Dev Biol. 2007. 51(3):241-6', 'Spata2 (spermatogenesis-associated protein 2) was originally described as a novel gene involved in the spermatogenic process. In this study, we cloned a potential zebrafish spata2 orthologue. The consensus open reading frame (1650 bp) encodes a polypeptide of 550 amino acids which shares 37% identity with the human SPATA2. Bioinformatic analysis reveals a small pattern PW [KR] KE [YF][RK] which seems to be of particular interest in the light of its strong conservation between SPATA2 and the recently discovered TAMO protein of D. melanogaster. RT-PCR analysis in adult zebrafish tissues revealed that spata2 mRNA has a broad distribution. Whole-mount in situ hybridization demonstrated that spata2 transcripts are maternally derived and becomes strongly localized in the central nervous system at early developmental stages. From 5 dpf, spata2 expression becomes detectable in the gut and pronephric duct epithelium, suggesting a wide tissue function during vertebrate development.', NULL, '2007', 'Zebrafish spata2 is expressed at early developmental stages.', '2021-11-30 07:45:11', '2021-11-30 07:45:11', 'Moro E, Maran C, Slongo ML, Argenton F, Toppo S, Onisto M', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">17486545</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2007</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">0214-6282</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>51</Volume><Issue>3</Issue><PubDate><Year>2007</Year></PubDate></JournalIssue><Title>The International journal of developmental biology</Title><ISOAbbreviation>Int J Dev Biol</ISOAbbreviation></Journal><ArticleTitle>Zebrafish spata2 is expressed at early developmental stages.</ArticleTitle><Pagination><MedlinePgn>241-6</MedlinePgn></Pagination><Abstract><AbstractText>Spata2 (spermatogenesis-associated protein 2) was originally described as a novel gene involved in the spermatogenic process. In this study, we cloned a potential zebrafish spata2 orthologue. The consensus open reading frame (1650 bp) encodes a polypeptide of 550 amino acids which shares 37% identity with the human SPATA2. Bioinformatic analysis reveals a small pattern PW [KR] KE [YF][RK] which seems to be of particular interest in the light of its strong conservation between SPATA2 and the recently discovered TAMO protein of D. melanogaster. RT-PCR analysis in adult zebrafish tissues revealed that spata2 mRNA has a broad distribution. Whole-mount in situ hybridization demonstrated that spata2 transcripts are maternally derived and becomes strongly localized in the central nervous system at early developmental stages. From 5 dpf, spata2 expression becomes detectable in the gut and pronephric duct epithelium, suggesting a wide tissue function during vertebrate development.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Moro</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dept. of Biology, University of Padua, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maran</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Author><Author ValidYN=\"Y\"><LastName>Slongo</LastName><ForeName>M Liliana</ForeName><Initials>ML</Initials></Author><Author ValidYN=\"Y\"><LastName>Argenton</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN=\"Y\"><LastName>Toppo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Author><Author ValidYN=\"Y\"><LastName>Onisto</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Int J Dev Biol</MedlineTA><NlmUniqueID>8917470</NlmUniqueID><ISSNLinking>0214-6282</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D020413\">3\' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D020121\">5\' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018388\">Codon, Terminator</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018076\">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D012333\">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C522426\">Spata2 protein, zebrafish</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D029961\">Zebrafish Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D020413\" MajorTopicYN=\"N\">3\' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020121\" MajorTopicYN=\"N\">5\' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000595\" MajorTopicYN=\"N\">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001483\" MajorTopicYN=\"N\">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003001\" MajorTopicYN=\"N\">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018388\" MajorTopicYN=\"N\">Codon, Terminator</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019295\" MajorTopicYN=\"N\">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016384\" MajorTopicYN=\"N\">Consensus Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018076\" MajorTopicYN=\"N\">DNA, Complementary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004625\" MajorTopicYN=\"N\">Embryo, Nonmammalian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018507\" MajorTopicYN=\"Y\">Gene Expression Regulation, Developmental</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017403\" MajorTopicYN=\"N\">In Situ Hybridization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008969\" MajorTopicYN=\"N\">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016366\" MajorTopicYN=\"N\">Open Reading Frames</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009928\" MajorTopicYN=\"N\">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016133\" MajorTopicYN=\"N\">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017433\" MajorTopicYN=\"N\">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017434\" MajorTopicYN=\"N\">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012333\" MajorTopicYN=\"N\">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017386\" MajorTopicYN=\"N\">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013091\" MajorTopicYN=\"N\">Spermatogenesis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013737\" MajorTopicYN=\"N\">Testis</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014018\" MajorTopicYN=\"N\">Tissue Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015027\" MajorTopicYN=\"N\">Zebrafish</DescriptorName><QualifierName UI=\"Q000196\" MajorTopicYN=\"Y\">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D029961\" MajorTopicYN=\"N\">Zebrafish Proteins</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2007</Year><Month>5</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2007</Year><Month>9</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2007</Year><Month>5</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">17486545</ArticleId><ArticleId IdType=\"pii\">062220em</ArticleId><ArticleId IdType=\"doi\">10.1387/ijdb.062220em</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 17486545, -0.2318, '2007-05-09', '2007-05-08');
INSERT INTO `document_caches` VALUES (18364390, 'Hum Mol Genet. 2008 Jul 1. 17(13). doi: 10.1093/hmg/ddn091:1938-45', 'Psoriasis is an immune-mediated skin disorder that is inherited as a multifactorial trait. Linkage studies have clearly identified a primary disease susceptibility locus lying within the major histocompatibility complex (MHC), but have generated conflicting results for other genomic regions. To overcome this difficulty, we have carried out a genome-wide association scan, where we analyzed more than 408,000 SNPs in an initial sample of 318 cases and 288 controls. Outside of the MHC, we observed a single cluster of disease-associated markers, spanning 47 kb on chromosome 20q13. The analysis of two replication data sets confirmed this association, with SNP rs495337 yielding a combined P-value of 1.4 x 10(-8) in an overall sample of 2679 cases and 2215 controls. Rs495337 maps to the SPATA2 transcript and is in absolute linkage disequilibrium with five SNPs lying in the adjacent ZNF313 gene (also known as RNF114). Real-time PCR experiments showed that, unlike SPATA2, ZNF313 is abundantly expressed in skin, T-lymphocytes and dendritic cells. Furthermore, an analysis of the expression data available from the Genevar database indicated that rs495337 is associated with increased ZNF313 transcripts levels (P = 0.003), suggesting that the disease susceptibility allele may be a ZNF313 regulatory variant tagged by rs495337. Homology searches indicated that ZNF313 is a paralogue of TRAC-1, an ubiquitin ligase regulating T-cell activation. We performed cell-free assays and confirmed that like TRAC-1, ZNF313 binds ubiquitin via an ubiquitin-interaction motif (UIM). These findings collectively identify a novel psoriasis susceptibility gene, with a putative role in the regulation of immune responses.', NULL, '2008', 'Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene.', '2021-11-30 07:44:58', '2021-11-30 07:44:58', 'Capon F, Bijlmakers MJ, Wolf N, Quaranta M, Huffmeier U, Allen M, Timms K, Abkevich V, Gutin A, Smith R, Warren RB, Young HS, Worthington J, Burden AD, Griffiths CE, Hayday A, Nestle FO, Reis A, Lanchbury J, Barker JN, Trembath RC', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">18364390</PMID><DateCompleted><Year>2008</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1460-2083</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>17</Volume><Issue>13</Issue><PubDate><Year>2008</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene.</ArticleTitle><Pagination><MedlinePgn>1938-45</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1093/hmg/ddn091</ELocationID><Abstract><AbstractText>Psoriasis is an immune-mediated skin disorder that is inherited as a multifactorial trait. Linkage studies have clearly identified a primary disease susceptibility locus lying within the major histocompatibility complex (MHC), but have generated conflicting results for other genomic regions. To overcome this difficulty, we have carried out a genome-wide association scan, where we analyzed more than 408,000 SNPs in an initial sample of 318 cases and 288 controls. Outside of the MHC, we observed a single cluster of disease-associated markers, spanning 47 kb on chromosome 20q13. The analysis of two replication data sets confirmed this association, with SNP rs495337 yielding a combined P-value of 1.4 x 10(-8) in an overall sample of 2679 cases and 2215 controls. Rs495337 maps to the SPATA2 transcript and is in absolute linkage disequilibrium with five SNPs lying in the adjacent ZNF313 gene (also known as RNF114). Real-time PCR experiments showed that, unlike SPATA2, ZNF313 is abundantly expressed in skin, T-lymphocytes and dendritic cells. Furthermore, an analysis of the expression data available from the Genevar database indicated that rs495337 is associated with increased ZNF313 transcripts levels (P = 0.003), suggesting that the disease susceptibility allele may be a ZNF313 regulatory variant tagged by rs495337. Homology searches indicated that ZNF313 is a paralogue of TRAC-1, an ubiquitin ligase regulating T-cell activation. We performed cell-free assays and confirmed that like TRAC-1, ZNF313 binds ubiquitin via an ubiquitin-interaction motif (UIM). These findings collectively identify a novel psoriasis susceptibility gene, with a putative role in the regulation of immune responses.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Capon</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Genetics and Molecular Medicine, Infection and Inflammatory Disease, King\'s College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bijlmakers</LastName><ForeName>Marie-José</ForeName><Initials>MJ</Initials></Author><Author ValidYN=\"Y\"><LastName>Wolf</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Author><Author ValidYN=\"Y\"><LastName>Quaranta</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN=\"Y\"><LastName>Huffmeier</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials></Author><Author ValidYN=\"Y\"><LastName>Allen</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN=\"Y\"><LastName>Timms</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials></Author><Author ValidYN=\"Y\"><LastName>Abkevich</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN=\"Y\"><LastName>Gutin</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>Rhodri</ForeName><Initials>R</Initials></Author><Author ValidYN=\"Y\"><LastName>Warren</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials></Author><Author ValidYN=\"Y\"><LastName>Young</LastName><ForeName>Helen S</ForeName><Initials>HS</Initials></Author><Author ValidYN=\"Y\"><LastName>Worthington</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Author><Author ValidYN=\"Y\"><LastName>Burden</LastName><ForeName>A David</ForeName><Initials>AD</Initials></Author><Author ValidYN=\"Y\"><LastName>Griffiths</LastName><ForeName>Christopher E M</ForeName><Initials>CE</Initials></Author><Author ValidYN=\"Y\"><LastName>Hayday</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Nestle</LastName><ForeName>Frank O</ForeName><Initials>FO</Initials></Author><Author ValidYN=\"Y\"><LastName>Reis</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Lanchbury</LastName><ForeName>Jerry</ForeName><Initials>J</Initials></Author><Author ValidYN=\"Y\"><LastName>Barker</LastName><ForeName>Jonathan N</ForeName><Initials>JN</Initials></Author><Author ValidYN=\"Y\"><LastName>Trembath</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>G0500449</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>068545/Z/02</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0601387</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0000934</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>17552</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>071534</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2008</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D002352\">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011993\">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025801\">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"C477146\">RNF114 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"D044767\">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002352\" MajorTopicYN=\"N\">Carrier Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020022\" MajorTopicYN=\"Y\">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015894\" MajorTopicYN=\"N\">Genome, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005838\" MajorTopicYN=\"N\">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015810\" MajorTopicYN=\"N\">Linkage Disequilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020641\" MajorTopicYN=\"N\">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011565\" MajorTopicYN=\"N\">Psoriasis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011993\" MajorTopicYN=\"N\">Recombinant Fusion Proteins</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020133\" MajorTopicYN=\"N\">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D025801\" MajorTopicYN=\"N\">Ubiquitin</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044767\" MajorTopicYN=\"N\">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006113\" MajorTopicYN=\"N\" Type=\"Geographic\">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2008</Year><Month>3</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2008</Year><Month>7</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2008</Year><Month>3</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">18364390</ArticleId><ArticleId IdType=\"pii\">ddn091</ArticleId><ArticleId IdType=\"doi\">10.1093/hmg/ddn091</ArticleId><ArticleId IdType=\"pmc\">PMC2900900</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Invest Dermatol. 2002 May;118(5):745-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11982750</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Jul 21;370(9583):263-271</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17658397</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2003 Dec;35(4):349-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14608357</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Nov;39(11):1299-301</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17968342</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2007 May;31(4):288-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17266119</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem J. 2008 Feb 15;410(1):101-11</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17990982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2007 Sep;122(2):201-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17587057</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Feb;80(2):273-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17236132</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2005 Dec;5(12):941-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16322747</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 2006 Jan;43(1):12-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15923274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Clin. 2004 Oct;22(4):339-47, vii</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15450331</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2007 Jan 12;315(5809):201-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17218518</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Jan 13;403(6766):211-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10646608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 2004 Jun;41(6):459-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15173233</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2005 Dec;1(6):e78</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16362079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 2008 Feb;45(2):114-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17993580</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 May 1;174(9):5288-97</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15843525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Jun 15;405(6788):847-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10866211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Nov;39(11):1329-37</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17952073</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2006 Feb;35(1):34-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16155052</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2005 Jan;124(1):107-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15654961</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2007 Jan;8(1):57-68</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17159887</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2005 May 26;435(7041):452-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15917799</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cell Biol. 2000 Oct;10(10):429-39</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2003 Oct;5(10):845-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14523392</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Jan 15;21(2):263-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 1998 Feb;18(2):143-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9462742</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 2001 Dec;25(4):402-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2005 Oct 5;24(19):3353-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16148945</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12958120</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 18364390, 0.0606, '2008-03-28', '2021-10-27');
INSERT INTO `document_caches` VALUES (25264125, 'Int J Immunogenet. 2014 Dec 27. 41(6). doi: 10.1111/iji.12150:503-7', 'Psoriasis is a chronic inflammatory skin disease occurred under the interaction of genetic and environmental factors. The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies. The aim of this study was to investigate whether the HCP5, TNIP1, TNFAIP3, SPATA2 and COG6 genes were genetic risk factors for psoriasis in Chinese population. One single nucleotide polymorphism (SNP) from each gene was evaluated using Chinese patients with psoriasis (n = 201) and controls (n = 300). The results demonstrated that SNPs rs2395029, rs17728338 and rs610604 from the HCP5, TNIP1 and TNFAIP3 genes, respectively, were associated with psoriasis in the studied population at both genotype level and allelic level (P < 0.05). Thus, the data suggested that HCP5, TNIP1 and TNFAIP3 may play a role in common pathogenic of psoriasis in Chinese and confer risk factors for psoriasis in various ethnic populations. These results provide potential makers for diagnosing, treating and preventing the psoriasis.', NULL, '2014', 'Investigating the genetic association of HCP5, SPATA2, TNIP1, TNFAIP3 and COG6 with psoriasis in Chinese population.', '2021-11-30 07:45:03', '2021-11-30 07:45:03', 'Li XL, Yu H, Wu GS', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">25264125</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1744-313X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>International journal of immunogenetics</Title><ISOAbbreviation>Int J Immunogenet</ISOAbbreviation></Journal><ArticleTitle>Investigating the genetic association of HCP5, SPATA2, TNIP1, TNFAIP3 and COG6 with psoriasis in Chinese population.</ArticleTitle><Pagination><MedlinePgn>503-7</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/iji.12150</ELocationID><Abstract><AbstractText>Psoriasis is a chronic inflammatory skin disease occurred under the interaction of genetic and environmental factors. The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies. The aim of this study was to investigate whether the HCP5, TNIP1, TNFAIP3, SPATA2 and COG6 genes were genetic risk factors for psoriasis in Chinese population. One single nucleotide polymorphism (SNP) from each gene was evaluated using Chinese patients with psoriasis (n = 201) and controls (n = 300). The results demonstrated that SNPs rs2395029, rs17728338 and rs610604 from the HCP5, TNIP1 and TNFAIP3 genes, respectively, were associated with psoriasis in the studied population at both genotype level and allelic level (P &lt; 0.05). Thus, the data suggested that HCP5, TNIP1 and TNFAIP3 may play a role in common pathogenic of psoriasis in Chinese and confer risk factors for psoriasis in various ethnic populations. These results provide potential makers for diagnosing, treating and preventing the psoriasis.</AbstractText><CopyrightInformation>© 2014 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>X-L</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Dermatology and Rheumatology, Affiliated Yan\'an Hospital of Kunming Medical University, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yu</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>G-S</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2014</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Immunogenet</MedlineTA><NlmUniqueID>101232337</NlmUniqueID><ISSNLinking>1744-3121</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D033942\">Adaptor Proteins, Vesicular Transport</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C115632\">COG5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D004268\">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C080521\">HCP5 long noncoding RNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D047908\">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D009687\">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D062085\">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D022661\">RNA, Untranslated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C117046\">TNIP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"C076529\">TNFAIP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000072598\">Tumor Necrosis Factor alpha-Induced Protein 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D033942\" MajorTopicYN=\"N\">Adaptor Proteins, Vesicular Transport</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044466\" MajorTopicYN=\"N\">Asian Continental Ancestry Group</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016022\" MajorTopicYN=\"N\">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002681\" MajorTopicYN=\"N\">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004268\" MajorTopicYN=\"N\">DNA-Binding Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D056726\" MajorTopicYN=\"N\">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020022\" MajorTopicYN=\"Y\">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D047908\" MajorTopicYN=\"N\">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008285\" MajorTopicYN=\"N\">Major Histocompatibility Complex</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D009687\" MajorTopicYN=\"N\">Nuclear Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012150\" MajorTopicYN=\"N\">Polymorphism, Restriction Fragment Length</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020641\" MajorTopicYN=\"N\">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011565\" MajorTopicYN=\"N\">Psoriasis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D062085\" MajorTopicYN=\"N\">RNA, Long Noncoding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D022661\" MajorTopicYN=\"N\">RNA, Untranslated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000072598\" MajorTopicYN=\"N\">Tumor Necrosis Factor alpha-Induced Protein 3</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2014</Year><Month>06</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2014</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2014</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2014</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2014</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2015</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">25264125</ArticleId><ArticleId IdType=\"doi\">10.1111/iji.12150</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 25264125, -0.0489, '2014-09-30', '2018-12-02');
INSERT INTO `document_caches` VALUES (27307491, 'EMBO J. 2016 Sep 1. 35(17). doi: 10.15252/embj.201694300:1868-84', 'TNF-α is a key regulator of innate immune and proinflammatory responses. However, the composition of the TNF-α receptor-associated signaling complexes (TNF-RSC) and the architecture of the downstream signaling networks are incompletely understood. We employed quantitative mass spectrometry to demonstrate that TNF-α stimulation induces widespread protein phosphorylation and that the scope of phosphorylation expands in a temporal manner. TNF-α stimulation also induces rapid ubiquitylation of components of the TNF-RSC Temporal analysis of the TNF-RSC composition identified SPATA2 as a novel component of the TNF-RSC The predicted PUB domain in the N-terminus of SPATA2 interacts with the USP domain of CYLD, whereas the C-terminus of SPATA2 interacts with HOIP SPATA2 is required for recruitment of CYLD to the TNF-RSC Downregulation of SPATA2 augments transcriptional activation of NF-κB and inhibits TNF-α-induced necroptosis, pointing to an important function of SPATA2 in modulating the outcomes of TNF-α signaling. Taken together, our study draws a detailed map of TNF-α signaling, identifies SPATA2 as a novel component of TNF-α signaling, and provides a rich resource for further functional investigations.', NULL, '2016', 'SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.', '2021-11-30 07:44:46', '2021-11-30 07:44:46', 'Wagner SA, Satpathy S, Beli P, Choudhary C', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">27307491</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1460-2075</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>35</Volume><Issue>17</Issue><PubDate><Year>2016</Year><Month>09</Month><Day>01</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.</ArticleTitle><Pagination><MedlinePgn>1868-84</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.15252/embj.201694300</ELocationID><Abstract><AbstractText>TNF-α is a key regulator of innate immune and proinflammatory responses. However, the composition of the TNF-α receptor-associated signaling complexes (TNF-RSC) and the architecture of the downstream signaling networks are incompletely understood. We employed quantitative mass spectrometry to demonstrate that TNF-α stimulation induces widespread protein phosphorylation and that the scope of phosphorylation expands in a temporal manner. TNF-α stimulation also induces rapid ubiquitylation of components of the TNF-RSC Temporal analysis of the TNF-RSC composition identified SPATA2 as a novel component of the TNF-RSC The predicted PUB domain in the N-terminus of SPATA2 interacts with the USP domain of CYLD, whereas the C-terminus of SPATA2 interacts with HOIP SPATA2 is required for recruitment of CYLD to the TNF-RSC Downregulation of SPATA2 augments transcriptional activation of NF-κB and inhibits TNF-α-induced necroptosis, pointing to an important function of SPATA2 in modulating the outcomes of TNF-α signaling. Taken together, our study draws a detailed map of TNF-α signaling, identifies SPATA2 as a novel component of TNF-α signaling, and provides a rich resource for further functional investigations.</AbstractText><CopyrightInformation>© 2016 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wagner</LastName><ForeName>Sebastian A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Proteomics, The Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Department of Medicine, Hematology/Oncology, Goethe University School of Medicine, Frankfurt, Germany German Cancer Consortium (DKTK), Heidelberg, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany swagner@med.uni-frankfurt.de chuna.choudhary@cpr.ku.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Satpathy</LastName><ForeName>Shankha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Proteomics, The Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Beli</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Proteomics, The Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Institute of Molecular Biology (IMB), Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Choudhary</LastName><ForeName>Chunaram</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0002-9863-433X</Identifier><AffiliationInfo><Affiliation>Department of Proteomics, The Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark swagner@med.uni-frankfurt.de chuna.choudhary@cpr.ku.dk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2016</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D020543\">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018124\">Receptors, Tumor Necrosis Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D014409\">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025521\">Tumor Suppressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"C558338\">RNF31 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"D044767\">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"C409984\">CYLD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000074749\">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType=\"CommentIn\"><RefSource>EMBO J. 2016 Sep 1;35(17 ):1848-50</RefSource><PMID Version=\"1\">27470000</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI=\"D002460\" MajorTopicYN=\"N\">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000074749\" MajorTopicYN=\"N\">Deubiquitinating Enzyme CYLD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013058\" MajorTopicYN=\"N\">Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010766\" MajorTopicYN=\"N\">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D025941\" MajorTopicYN=\"N\">Protein Interaction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011499\" MajorTopicYN=\"N\">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020543\" MajorTopicYN=\"N\">Proteome</DescriptorName><QualifierName UI=\"Q000032\" MajorTopicYN=\"N\">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018124\" MajorTopicYN=\"N\">Receptors, Tumor Necrosis Factor</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"Y\">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014409\" MajorTopicYN=\"N\">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D025521\" MajorTopicYN=\"N\">Tumor Suppressor Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044767\" MajorTopicYN=\"N\">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D054875\" MajorTopicYN=\"N\">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">CYLD</Keyword><Keyword MajorTopicYN=\"Y\">LUBAC</Keyword><Keyword MajorTopicYN=\"Y\">SPATA2</Keyword><Keyword MajorTopicYN=\"Y\">TNF‐RSC</Keyword><Keyword MajorTopicYN=\"Y\">necroptosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2016</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2016</Year><Month>05</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId><ArticleId IdType=\"pii\">embj.201694300</ArticleId><ArticleId IdType=\"doi\">10.15252/embj.201694300</ArticleId><ArticleId IdType=\"pmc\">PMC5007551</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Methods. 2007 Mar;4(3):207-14</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17327847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D222-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25414356</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2011 Nov;244(1):9-28</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22017428</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Syst Biol. 2015 Jun 02;11(6):810</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26038114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2012 Jan 20;148(1-2):213-27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22265413</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1994 Apr 1;264(5155):95-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8140422</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 2004 Dec 29;14(24):2217-27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15620648</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2013 Mar;8(3):461-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23391890</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jun 20;498(7454):318-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23708998</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1997 Mar 17;16(6):1413-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9135156</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2005 Aug;7(8):758-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16056267</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunol. 2014 Jun;26(3):237-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24647229</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1995 Mar 10;267(5203):1485-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7878466</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2013 Sep 19;39(3):443-53</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24012422</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2011 Oct;23(5):620-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21920725</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e23061</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21829693</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2007;2(10):2366-82</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17947979</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2011 Oct 28;286(43):37147-57</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21896478</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2007 Mar;14(3):400-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17301840</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 May 31;296(5573):1634-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12040173</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):801-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Jul 23;138(2):229-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19632174</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2007 Sep;4(9):709-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17721543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2013 Jun 27;50(6):818-830</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23806334</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteome Res. 2012 Jun 1;11(6):3487-97</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22537090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Proteomics. 2011 Sep;10(9):M111.011015</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21642640</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2002 Jan;9(1):20-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11803371</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2003 Jun 15;17(12):1487-96</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12815069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2008 Dec;26(12):1367-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2008 Jan;214(2):149-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18161752</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Jun 12;137(6):1100-11</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19524512</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2011 Jul 8;333(6039):228-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 02;8(10):e76841</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24098568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2001 Sep;8(3):613-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11583623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2011 Oct 21;44(2):325-40</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21906983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteome Res. 2011 Apr 1;10(4):1794-805</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21254760</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):793-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2011 Nov 16;12(12):1143-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22089220</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Dec 26;135(7):1311-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):335-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2001 Feb;7(2):401-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11239468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Proteomics. 2011 Oct;10(10):M111.013284</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21890473</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2003 Sep;3(9):745-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12949498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2007;2(8):1896-906</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17703201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2013 Jun 6;153(6):1312-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23746843</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biochem. 2012;81:379-405</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22439968</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2008 Jun 12;27(26):3739-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18212736</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cells. 2014 Mar;19(3):254-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24461064</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D561-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21045058</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2013 Aug 29;4(4):842-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23954790</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Proteomics. 2002 May;1(5):376-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12118079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2006 Nov 3;127(3):635-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17081983</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2009 Feb;11(2):123-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19136968</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):797-801</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2013 Feb;12(2):147-68</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23334208</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2005 Jul;1(2):112-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16408008</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2000;18:621-63</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10837071</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2001 Feb 23;104(4):487-501</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11239407</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 2014;545:35-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25065885</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):349-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2013 Aug;23(8):994-1006</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23835476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Proteomics. 2013 Dec;12(12):3444-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24187339</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2009 Nov;6(11):786-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19876014</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2014 Aug;15(8):503-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25027653</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2001 Jun 1;498(1):93-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11389905</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2011 Oct 30;13(12):1437-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22037414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2011 Jan;21(1):22-39</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21119682</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2010 Jun;11(6):427-39</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20461098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2012 Oct 23;5(247):pe47</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23092889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 27307491, 0.4688, '2016-06-17', '2021-01-09');
INSERT INTO `document_caches` VALUES (27458237, 'EMBO Rep. 2016 Oct 25. 17(10):1485-1497', 'K63- and Met1-linked ubiquitylation are crucial posttranslational modifications for TNF receptor signaling. These non-degradative ubiquitylations are counteracted by deubiquitinases (DUBs), such as the enzyme CYLD, resulting in an appropriate signal strength, but the regulation of this process remains incompletely understood. Here, we describe an interaction partner of CYLD, SPATA2, which we identified by a mass spectrometry screen. We find that SPATA2 interacts via its PUB domain with CYLD, while a PUB interaction motif (PIM) of SPATA2 interacts with the PUB domain of the LUBAC component HOIP SPATA2 is required for the recruitment of CYLD to the TNF receptor signaling complex upon TNFR stimulation. Moreover, SPATA2 acts as an allosteric activator for the K63- and M1-deubiquitinase activity of CYLD In consequence, SPATA2 substantially attenuates TNF-induced NF-κB and MAPK signaling. Conversely, SPATA2 is required for TNF-induced complex II formation, caspase activation, and apoptosis. Thus, this study identifies SPATA2 as an important factor in the TNF signaling pathway with a substantial role for the effects mediated by the cytokine.', NULL, '2016', 'SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.', '2021-11-30 07:44:41', '2021-11-30 07:44:41', 'Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, Maurer U', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">27458237</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1469-3178</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2016</Year><Month>10</Month></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep</ISOAbbreviation></Journal><ArticleTitle>SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.</ArticleTitle><Pagination><MedlinePgn>1485-1497</MedlinePgn></Pagination><Abstract><AbstractText>K63- and Met1-linked ubiquitylation are crucial posttranslational modifications for TNF receptor signaling. These non-degradative ubiquitylations are counteracted by deubiquitinases (DUBs), such as the enzyme CYLD, resulting in an appropriate signal strength, but the regulation of this process remains incompletely understood. Here, we describe an interaction partner of CYLD, SPATA2, which we identified by a mass spectrometry screen. We find that SPATA2 interacts via its PUB domain with CYLD, while a PUB interaction motif (PIM) of SPATA2 interacts with the PUB domain of the LUBAC component HOIP SPATA2 is required for the recruitment of CYLD to the TNF receptor signaling complex upon TNFR stimulation. Moreover, SPATA2 acts as an allosteric activator for the K63- and M1-deubiquitinase activity of CYLD In consequence, SPATA2 substantially attenuates TNF-induced NF-κB and MAPK signaling. Conversely, SPATA2 is required for TNF-induced complex II formation, caspase activation, and apoptosis. Thus, this study identifies SPATA2 as an important factor in the TNF signaling pathway with a substantial role for the effects mediated by the cytokine.</AbstractText><CopyrightInformation>© 2016 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Schlicher</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wissler</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Preiss</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brauns-Schubert</LastName><ForeName>Prisca</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jakob</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dumit</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Core Facility Proteomics, Center for Biological Systems Analysis, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Borner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dengjel</LastName><ForeName>Joern</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany Core Facility Proteomics, Center for Biological Systems Analysis, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maurer</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><Identifier Source=\"ORCID\">0000-0002-2504-1517</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany ulrich.maurer@mol-med.uni-freiburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2016</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D046912\">Multiprotein Complexes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016328\">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D014409\">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025521\">Tumor Suppressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"D044767\">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"C409984\">CYLD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000074749\">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType=\"CommentIn\"><RefSource>EMBO J. 2016 Sep 1;35(17 ):1848-50</RefSource><PMID Version=\"1\">27470000</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D064113\" MajorTopicYN=\"N\">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016923\" MajorTopicYN=\"N\">Cell Death</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002460\" MajorTopicYN=\"N\">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000074749\" MajorTopicYN=\"N\">Deubiquitinating Enzyme CYLD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055786\" MajorTopicYN=\"N\">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018390\" MajorTopicYN=\"N\">Gene Targeting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020935\" MajorTopicYN=\"N\">MAP Kinase Signaling System</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008954\" MajorTopicYN=\"N\">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D046912\" MajorTopicYN=\"N\">Multiprotein Complexes</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016328\" MajorTopicYN=\"N\">NF-kappa B</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011485\" MajorTopicYN=\"N\">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"Y\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014409\" MajorTopicYN=\"N\">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"Y\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D025521\" MajorTopicYN=\"N\">Tumor Suppressor Proteins</DescriptorName><QualifierName UI=\"Q000172\" MajorTopicYN=\"N\">deficiency</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044767\" MajorTopicYN=\"N\">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">CYLD</Keyword><Keyword MajorTopicYN=\"Y\">HOIP</Keyword><Keyword MajorTopicYN=\"Y\">SPATA2</Keyword><Keyword MajorTopicYN=\"Y\">TNF</Keyword><Keyword MajorTopicYN=\"Y\">apoptosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2016</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2016</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2017</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2016</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId><ArticleId IdType=\"pii\">embr.201642592</ArticleId><ArticleId IdType=\"doi\">10.15252/embr.201642592</ArticleId><ArticleId IdType=\"pmc\">PMC5048381</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mol Cell. 2004 Aug 27;15(4):535-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15327770</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17(10):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2008 Jul 1;17(13):1938-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18364390</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2005 Nov;6(11):1087-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16186825</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 May 16;133(4):693-703</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18485876</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2007;2(8):1896-906</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17703201</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2011 Nov;244(1):9-28</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22017428</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1995 Feb 25;23(4):628-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7899083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2013 Oct;20(10):1381-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23892367</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):591-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Mar 29;14(12):2846-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26997266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Oct 23;36(2):302-14</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19854138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):633-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455180</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2007 Nov 16;131(4):669-81</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18022362</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Aug 27;5:4763</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25159004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Dec 11;36(5):831-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20005846</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):801-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917691</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2007 Nov;13(5):705-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17981138</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Cell Res. 1999 May 1;248(2):620-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10222154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):793-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917689</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2009 Dec 18;284(51):35906-15</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19815541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Dec 26;135(7):1311-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2007 Nov 16;131(4):682-93</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18022363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):335-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Jul 19;412(6844):346-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11460167</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2003 Jul 25;114(2):181-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12887920</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 2007 Mar 6;17(5):418-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17306544</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2012 May 4;418(3-4):134-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22227388</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2009 May;10(5):466-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373254</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2014 Aug;11(8):783-784</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25075903</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Nov 15;177(10):7122-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17082629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2015 Oct 1;60(1):63-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26344099</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cells. 2014 Mar;19(3):254-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24461064</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2008 Sep 5;283(36):24295-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18621737</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Immunogenet. 2014 Dec;41(6):503-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25264125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2008 Jun 20;30(6):689-700</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18570872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2006;1(6):2856-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17406544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):797-801</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):349-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2008 Feb 29;29(4):451-64</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18313383</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2001 Aug;21(16):5299-305</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11463813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):637-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455181</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jan 18;6:19507</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26776505</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2011 Apr;18(4):656-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21052097</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2014 Oct 9;9(1):153-165</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25284787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2011 Dec 11;19(1):62-71</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22157957</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endocrinol Invest. 2000 Oct;23(9):605-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11079456</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2007 Nov;12(5):445-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17996648</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 27458237, 0.8537, NULL, '2021-01-09');
INSERT INTO `document_caches` VALUES (27470000, 'EMBO J. 2016 Sep 1. 35(17). doi: 10.15252/embj.201695061:1848-50', '', NULL, '2016', 'SPATA2 - Keeping the TNF signal short and sweet.', '2021-11-30 07:45:10', '2021-11-30 07:45:10', 'Feltham R, Webb AI, Silke J', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">27470000</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1460-2075</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>35</Volume><Issue>17</Issue><PubDate><Year>2016</Year><Month>09</Month><Day>01</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>SPATA2 - Keeping the TNF signal short and sweet.</ArticleTitle><Pagination><MedlinePgn>1848-50</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.15252/embj.201695061</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Feltham</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Webb</LastName><ForeName>Andrew I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Silke</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-7611-5774</Identifier><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016420\">Comment</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2016</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025521\">Tumor Suppressor Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType=\"CommentOn\"><RefSource>EMBO J. 2016 Sep 1;35(17 ):1868-84</RefSource><PMID Version=\"1\">27307491</PMID></CommentsCorrections><CommentsCorrections RefType=\"CommentOn\"><RefSource>EMBO Rep. 2016 Oct;17 (10 ):1485-1497</RefSource><PMID Version=\"1\">27458237</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"Y\">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013649\" MajorTopicYN=\"N\">Taste</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D025521\" MajorTopicYN=\"Y\">Tumor Suppressor Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"entrez\"><Year>2016</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2016</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2018</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">27470000</ArticleId><ArticleId IdType=\"pii\">embj.201695061</ArticleId><ArticleId IdType=\"doi\">10.15252/embj.201695061</ArticleId><ArticleId IdType=\"pmc\">PMC5007556</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dev Cell. 2007 Nov;13(5):705-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17981138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Feb 6;385(6616):540-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9020361</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17 (10 ):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Aug;10(8):730-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23921808</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 02;8(10 ):e76841</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24098568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10 ):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endocrinol Invest. 2000 Oct;23(9):605-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11079456</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Sci. 2011 Feb 15;124(Pt 4):647-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21266470</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2011 Apr 15;286(15):13282-91</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21339290</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Cell Res. 1999 May 1;248(2):620-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10222154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):591-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 27470000, -0.2069, NULL, '2018-12-02');
INSERT INTO `document_caches` VALUES (27545878, 'Cell Rep. 2016 Aug 30. 16(9). doi: 10.1016/j.celrep.2016.07.086. pii: S2211-1247(16)31033-6:2271-80', 'Recruitment of the deubiquitinase CYLD to signaling complexes is mediated by its interaction with HOIP, the catalytically active component of the linear ubiquitin chain assembly complex (LUBAC). Here, we identify SPATA2 as a constitutive direct binding partner of HOIP that bridges the interaction between CYLD and HOIP. SPATA2 recruitment to TNFR1- and NOD2-signaling complexes is dependent on HOIP, and loss of SPATA2 abolishes CYLD recruitment. Deficiency in SPATA2 exerts limited effects on gene activation pathways but diminishes necroptosis induced by tumor necrosis factor (TNF), resembling loss of CYLD. In summary, we describe SPATA2 as a previously unrecognized factor in LUBAC-dependent signaling pathways that serves as an adaptor between HOIP and CYLD, thereby enabling recruitment of CYLD to signaling complexes.', NULL, '2016', 'SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.', '2021-11-30 07:44:42', '2021-11-30 07:44:42', 'Kupka S, De Miguel D, Draber P, Martino L, Surinova S, Rittinger K, Walczak H', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">27545878</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2211-1247</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>08</Month><Day>30</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.</ArticleTitle><Pagination><MedlinePgn>2271-80</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.celrep.2016.07.086</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S2211-1247(16)31033-6</ELocationID><Abstract><AbstractText>Recruitment of the deubiquitinase CYLD to signaling complexes is mediated by its interaction with HOIP, the catalytically active component of the linear ubiquitin chain assembly complex (LUBAC). Here, we identify SPATA2 as a constitutive direct binding partner of HOIP that bridges the interaction between CYLD and HOIP. SPATA2 recruitment to TNFR1- and NOD2-signaling complexes is dependent on HOIP, and loss of SPATA2 abolishes CYLD recruitment. Deficiency in SPATA2 exerts limited effects on gene activation pathways but diminishes necroptosis induced by tumor necrosis factor (TNF), resembling loss of CYLD. In summary, we describe SPATA2 as a previously unrecognized factor in LUBAC-dependent signaling pathways that serves as an adaptor between HOIP and CYLD, thereby enabling recruitment of CYLD to signaling complexes.</AbstractText><CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kupka</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Cell Death, Cancer, and Inflammation (CCCI), UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Miguel</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Cell Death, Cancer, and Inflammation (CCCI), UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Draber</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for Cell Death, Cancer, and Inflammation (CCCI), UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Martino</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London NW1 1BF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Surinova</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Cell Death, Cancer, and Inflammation (CCCI), UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rittinger</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London NW1 1BF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Walczak</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Cell Death, Cancer, and Inflammation (CCCI), UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK. Electronic address: h.walczak@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>MC_U117565398</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>508528</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>A17341</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2016</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C429018\">NOD2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D053473\">Nod2 Signaling Adaptor Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D047888\">Receptors, Tumor Necrosis Factor, Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011994\">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D014409\">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025521\">Tumor Suppressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025801\">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"C558338\">RNF31 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"D044767\">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"C409984\">CYLD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000074749\">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001665\" MajorTopicYN=\"N\">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003001\" MajorTopicYN=\"N\">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000074749\" MajorTopicYN=\"N\">Deubiquitinating Enzyme CYLD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004926\" MajorTopicYN=\"N\">Escherichia coli</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005786\" MajorTopicYN=\"N\">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006367\" MajorTopicYN=\"N\">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008264\" MajorTopicYN=\"N\">Macrophages</DescriptorName><QualifierName UI=\"Q000166\" MajorTopicYN=\"N\">cytology</QualifierName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053473\" MajorTopicYN=\"N\">Nod2 Signaling Adaptor Protein</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010957\" MajorTopicYN=\"N\">Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D061251\" MajorTopicYN=\"N\">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011485\" MajorTopicYN=\"N\">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D047888\" MajorTopicYN=\"N\">Receptors, Tumor Necrosis Factor, Type I</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011994\" MajorTopicYN=\"N\">Recombinant Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"Y\">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014409\" MajorTopicYN=\"N\">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D025521\" MajorTopicYN=\"N\">Tumor Suppressor Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D025801\" MajorTopicYN=\"N\">Ubiquitin</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044767\" MajorTopicYN=\"N\">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2016</Year><Month>06</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2016</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2016</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2016</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2016</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2017</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">27545878</ArticleId><ArticleId IdType=\"pii\">S2211-1247(16)31033-6</ArticleId><ArticleId IdType=\"doi\">10.1016/j.celrep.2016.07.086</ArticleId><ArticleId IdType=\"pmc\">PMC5009064</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Drug Targets. 2015 ;16(4):284-94</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25342597</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2016 May 27;18(6):579-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27230526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytokine Growth Factor Rev. 2014 Aug;25(4):453-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25169849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Sci. 2016 May 1;129(9):1775-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27006117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2007 Nov;13(5):705-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17981138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):801-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 1995 Dec;11(4):441-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7493027</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15247-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23986494</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS J. 2016 Jul;283(14):2626-39</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26749412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):335-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Dec 11;36(5):831-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20005846</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2012 Aug 17;287(34):28705-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22718770</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Dec 26;135(7):1311-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Chem Biol. 2014 Dec;23:71-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25461388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):793-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917689</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS J. 2014 Oct;281(19):4337-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25060092</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Feb 13;33(3):275-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19217402</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cells. 2014 Mar;19(3):254-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24461064</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 02;8(10 ):e76841</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24098568</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biochem. 2016 Jun 2;85:743-63</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26865533</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10 ):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):349-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726327</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):637-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455181</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2012 Mar;246(1):107-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22435550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2006 Apr;7(4):411-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16501569</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):633-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455180</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2006 Oct 18;25(20):4877-87</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17006537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2011 Oct 30;13(12):1437-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22037414</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2014 Jan;15(1):28-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24375678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Immunol. 2011 Nov;8(6):502-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21946435</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):797-801</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917690</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2001 Apr 27;283(1):86-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11322771</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2014 Aug;15(8):503-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25027653</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Biol. 2012 Mar 15;10 :23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22420778</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2006 Nov;116(11):3042-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17053834</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2015 Feb 19;7:null</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25737804</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2010 Mar 12;37(5):607-19</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20227366</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 2008 May;45(5):298-302</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18234730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2014 Oct 9;9(1):153-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25284787</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2012 Jun 29;46(6):746-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22607974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):591-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 27545878, 0.8337, NULL, '2021-01-02');
INSERT INTO `document_caches` VALUES (27591049, 'Mol Cell. 2016 Sep 15. 63(6). doi: 10.1016/j.molcel.2016.08.001. pii: S1097-2765(16)30415-4:990-1005', 'The linear ubiquitin chain assembly complex (LUBAC) regulates immune signaling, and its function is regulated by the deubiquitinases OTULIN and CYLD, which associate with the catalytic subunit HOIP. However, the mechanism through which CYLD interacts with HOIP is unclear. We here show that CYLD interacts with HOIP via spermatogenesis-associated protein 2 (SPATA2). SPATA2 interacts with CYLD through its non-canonical PUB domain, which binds the catalytic CYLD USP domain in a CYLD B-box-dependent manner. Significantly, SPATA2 binding activates CYLD-mediated hydrolysis of ubiquitin chains. SPATA2 also harbors a conserved PUB-interacting motif that selectively docks into the HOIP PUB domain. In cells, SPATA2 is recruited to the TNF receptor 1 signaling complex and is required for CYLD recruitment. Loss of SPATA2 increases ubiquitination of LUBAC substrates and results in enhanced NOD2 signaling. Our data reveal SPATA2 as a high-affinity binding partner of CYLD and HOIP, and a regulatory component of LUBAC-mediated NF-κB signaling.', NULL, '2016', 'SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.', '2021-11-30 07:44:39', '2021-11-30 07:44:39', 'Elliott PR, Leske D, Hrdinka M, Bagola K, Fiil BK, McLaughlin SH, Wagstaff J, Volkmar N, Christianson JC, Kessler BM, Freund SM, Komander D, Gyrd-Hansen M', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">27591049</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-4164</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>63</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>09</Month><Day>15</Day></PubDate></JournalIssue><Title>Molecular cell</Title><ISOAbbreviation>Mol Cell</ISOAbbreviation></Journal><ArticleTitle>SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.</ArticleTitle><Pagination><MedlinePgn>990-1005</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.molcel.2016.08.001</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1097-2765(16)30415-4</ELocationID><Abstract><AbstractText>The linear ubiquitin chain assembly complex (LUBAC) regulates immune signaling, and its function is regulated by the deubiquitinases OTULIN and CYLD, which associate with the catalytic subunit HOIP. However, the mechanism through which CYLD interacts with HOIP is unclear. We here show that CYLD interacts with HOIP via spermatogenesis-associated protein 2 (SPATA2). SPATA2 interacts with CYLD through its non-canonical PUB domain, which binds the catalytic CYLD USP domain in a CYLD B-box-dependent manner. Significantly, SPATA2 binding activates CYLD-mediated hydrolysis of ubiquitin chains. SPATA2 also harbors a conserved PUB-interacting motif that selectively docks into the HOIP PUB domain. In cells, SPATA2 is recruited to the TNF receptor 1 signaling complex and is required for CYLD recruitment. Loss of SPATA2 increases ubiquitination of LUBAC substrates and results in enhanced NOD2 signaling. Our data reveal SPATA2 as a high-affinity binding partner of CYLD and HOIP, and a regulatory component of LUBAC-mediated NF-κB signaling.</AbstractText><CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Elliott</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leske</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hrdinka</LastName><ForeName>Matous</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bagola</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fiil</LastName><ForeName>Berthe K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McLaughlin</LastName><ForeName>Stephen H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wagstaff</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Volkmar</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Christianson</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kessler</LastName><ForeName>Benedikt M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>TDI Mass Spectrometry Laboratory, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Freund</LastName><ForeName>Stefan M V</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Komander</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. Electronic address: dk@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gyrd-Hansen</LastName><ForeName>Mads</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK. Electronic address: mads.gyrd-hansen@ludwig.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>309756</GrantID><Agency>European Research Council</Agency><Country>International</Country></Grant><Grant><GrantID>G0501068</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_U105192732</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L001209/1</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>102894/Z/13/Z</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>097813/Z/11/Z</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2016</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell</MedlineTA><NlmUniqueID>9802571</NlmUniqueID><ISSNLinking>1097-2765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016328\">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C429018\">NOD2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D053473\">Nod2 Signaling Adaptor Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011994\">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025521\">Tumor Suppressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D025801\">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"C558338\">RNF31 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"D044767\">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI=\"D010450\">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI=\"C582107\">OTULIN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"C409984\">CYLD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000074749\">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000595\" MajorTopicYN=\"N\">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001665\" MajorTopicYN=\"N\">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003001\" MajorTopicYN=\"N\">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018360\" MajorTopicYN=\"N\">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000074749\" MajorTopicYN=\"N\">Deubiquitinating Enzyme CYLD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010450\" MajorTopicYN=\"N\">Endopeptidases</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004926\" MajorTopicYN=\"N\">Escherichia coli</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015870\" MajorTopicYN=\"N\">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005786\" MajorTopicYN=\"N\">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007113\" MajorTopicYN=\"N\">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007700\" MajorTopicYN=\"N\">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D062105\" MajorTopicYN=\"N\">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016328\" MajorTopicYN=\"N\">NF-kappa B</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"Y\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D053473\" MajorTopicYN=\"N\">Nod2 Signaling Adaptor Protein</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011485\" MajorTopicYN=\"N\">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D054730\" MajorTopicYN=\"N\">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017433\" MajorTopicYN=\"N\">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"Y\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011994\" MajorTopicYN=\"N\">Recombinant Proteins</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016415\" MajorTopicYN=\"N\">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017386\" MajorTopicYN=\"N\">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013379\" MajorTopicYN=\"N\">Substrate Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D025521\" MajorTopicYN=\"N\">Tumor Suppressor Proteins</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"Y\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D025801\" MajorTopicYN=\"N\">Ubiquitin</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"Y\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044767\" MajorTopicYN=\"N\">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"Y\">chemistry</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2016</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2016</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2016</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2016</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2016</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2017</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">27591049</ArticleId><ArticleId IdType=\"pii\">S1097-2765(16)30415-4</ArticleId><ArticleId IdType=\"doi\">10.1016/j.molcel.2016.08.001</ArticleId><ArticleId IdType=\"pmc\">PMC5031558</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trends Biochem Sci. 2015 Aug;40(8):456-67</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26073511</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):801-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917691</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 2008 Oct 7;47(40):10722-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18795805</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jun 02;5:null</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27253059</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2009 May;10(5):466-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373254</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):335-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Dec 11;36(5):831-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20005846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Jul 23;138(2):389-403</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19615732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Dec 26;135(7):1311-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure. 2015 Nov 3;23(11):2043-54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26388029</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS J. 2014 Oct;281(19):4337-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25060092</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cells. 2014 Mar;19(3):254-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24461064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Mar 29;14 (12 ):2846-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26997266</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Aug 27;5:4763</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25159004</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Mol Med. 2013 Aug;5(8):1278-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23818254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10 ):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):349-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726327</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):637-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455181</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2012 Mar;246(1):107-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22435550</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2007 Jun 11;204(6):1475-85</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17548520</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2015 Jun 1;212(6):939-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26008899</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 May 22;104(21):8785-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17496150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):633-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455180</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2006 Oct 18;25(20):4877-87</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17006537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2011 Oct 30;13(12):1437-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22037414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2011 Dec 09;12(1):35-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22158412</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2015 Mar;22(3):222-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25686088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Jul 21;63(2):249-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27373336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2012 Dec;13(12 ):1178-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23104095</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2012 Jun 15;287(25):20823-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22549881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2013 Jun 6;153(6):1312-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23746843</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2012 Jun 29;46(6):746-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22607974</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2013 Jun 27;50(6):818-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23806334</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2012 Dec;68(Pt 12):1622-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23151627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):591-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2008 Feb 29;29(4):451-64</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18313383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 27591049, 0.9999, NULL, '2021-03-01');
INSERT INTO `document_caches` VALUES (27635695, 'Cell Cycle. 2017 Jan 2. 16(1). doi: 10.1080/15384101.2016.1232090:11-12', '', NULL, '2017', 'SPATA2: New insights into the assembly of the TNFR signaling complex.', '2021-11-30 07:45:01', '2021-11-30 07:45:01', 'Schlicher L, Maurer U', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">27635695</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1551-4005</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>01</Month><Day>02</Day></PubDate></JournalIssue><Title>Cell cycle (Georgetown, Tex.)</Title><ISOAbbreviation>Cell Cycle</ISOAbbreviation></Journal><ArticleTitle>SPATA2: New insights into the assembly of the TNFR signaling complex.</ArticleTitle><Pagination><MedlinePgn>11-12</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1080/15384101.2016.1232090</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Schlicher</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>a Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg , Freiburg , Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg , Freiburg , Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c BIOSS, Center for Biological Signaling Studies , Freiburg , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maurer</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>a Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg , Freiburg , Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg , Freiburg , Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c BIOSS, Center for Biological Signaling Studies , Freiburg , Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016421\">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2016</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Cycle</MedlineTA><NlmUniqueID>101137841</NlmUniqueID><ISSNLinking>1551-4005</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018124\">Receptors, Tumor Necrosis Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000074749\">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000074749\" MajorTopicYN=\"N\">Deubiquitinating Enzyme CYLD</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018124\" MajorTopicYN=\"N\">Receptors, Tumor Necrosis Factor</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"Y\">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">CYLD</Keyword><Keyword MajorTopicYN=\"Y\">HOIP</Keyword><Keyword MajorTopicYN=\"Y\">LUBAC</Keyword><Keyword MajorTopicYN=\"Y\">NF-kB</Keyword><Keyword MajorTopicYN=\"Y\">SPATA2</Keyword><Keyword MajorTopicYN=\"Y\">TNF</Keyword><Keyword MajorTopicYN=\"Y\">apoptosis</Keyword><Keyword MajorTopicYN=\"Y\">ubiquitylation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2016</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2018</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2016</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">27635695</ArticleId><ArticleId IdType=\"doi\">10.1080/15384101.2016.1232090</ArticleId><ArticleId IdType=\"pmc\">PMC5270513</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Death Differ. 2010 Jan;17 (1):25-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373246</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17 (10 ):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2011 Apr;18(4):656-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21052097</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10 ):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2008 Jun 20;30(6):689-700</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18570872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2014 Oct 9;9(1):153-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25284787</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 27635695, -0.0158, NULL, '2020-09-30');
INSERT INTO `document_caches` VALUES (28189684, 'Biochem Biophys Res Commun. 2017 Mar 25. 485(1). pii: S0006-291X(17)30308-X. doi: 10.1016/j.bbrc.2017.02.040:152-159', 'NF-κB is crucial to regulate immune and inflammatory responses and cell survival. LUBAC generates a linear ubiquitin chain and activates NF-κB through ubiquitin ligase (E3) activity in the HOIP subunit. Here, we show that HOIP is predominantly cleaved by caspase at Asp390 upon apoptosis, and that is subjected to proteasomal degradation. We identified that FADD, as well as NEMO, is a substrate for LUBAC. Although the C-terminal fragment of HOIP retains NF-κB activity, linear ubiquitination of NEMO and FADD decreases upon apoptosis. Moreover, the N-terminal fragment of HOIP binds with deubiquitinases, such as OTULIN and CYLD-SPATA2. These results indicate that caspase-mediated cleavage of HOIP divides critical functional regions of HOIP, and that this regulates linear (de)ubiquitination of substrates upon apoptosis.', NULL, '2017', 'Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP.', '2021-11-30 07:44:48', '2021-11-30 07:44:48', 'Goto E, Tokunaga F', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">28189684</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1090-2104</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>485</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>03</Month><Day>25</Day></PubDate></JournalIssue><Title>Biochemical and biophysical research communications</Title><ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation></Journal><ArticleTitle>Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP.</ArticleTitle><Pagination><MedlinePgn>152-159</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0006-291X(17)30308-X</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.bbrc.2017.02.040</ELocationID><Abstract><AbstractText>NF-κB is crucial to regulate immune and inflammatory responses and cell survival. LUBAC generates a linear ubiquitin chain and activates NF-κB through ubiquitin ligase (E3) activity in the HOIP subunit. Here, we show that HOIP is predominantly cleaved by caspase at Asp390 upon apoptosis, and that is subjected to proteasomal degradation. We identified that FADD, as well as NEMO, is a substrate for LUBAC. Although the C-terminal fragment of HOIP retains NF-κB activity, linear ubiquitination of NEMO and FADD decreases upon apoptosis. Moreover, the N-terminal fragment of HOIP binds with deubiquitinases, such as OTULIN and CYLD-SPATA2. These results indicate that caspase-mediated cleavage of HOIP divides critical functional regions of HOIP, and that this regulates linear (de)ubiquitination of substrates upon apoptosis.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Goto</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathobiochemistry, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tokunaga</LastName><ForeName>Fuminori</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathobiochemistry, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan. Electronic address: ftokunaga@med.osaka-cu.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2017</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C505533\">FADD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D053200\">Fas-Associated Death Domain Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C491731\">IKBKG protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016328\">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D014409\">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"C558338\">RNF31 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI=\"D044767\">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.10</RegistryNumber><NameOfSubstance UI=\"D051550\">I-kappa B Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI=\"D020169\">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D017209\" MajorTopicYN=\"Y\">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020169\" MajorTopicYN=\"N\">Caspases</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D053200\" MajorTopicYN=\"N\">Fas-Associated Death Domain Protein</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055786\" MajorTopicYN=\"N\">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D057809\" MajorTopicYN=\"N\">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051550\" MajorTopicYN=\"N\">I-kappa B Kinase</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D019169\" MajorTopicYN=\"N\">Jurkat Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016328\" MajorTopicYN=\"N\">NF-kappa B</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014409\" MajorTopicYN=\"N\">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D044767\" MajorTopicYN=\"N\">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D054875\" MajorTopicYN=\"Y\">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">Apoptosis</Keyword><Keyword MajorTopicYN=\"Y\">Caspase</Keyword><Keyword MajorTopicYN=\"Y\">Deubiquitinase</Keyword><Keyword MajorTopicYN=\"Y\">NF-κB</Keyword><Keyword MajorTopicYN=\"Y\">Ubiquitin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2017</Year><Month>02</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2017</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2017</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2017</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2017</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">28189684</ArticleId><ArticleId IdType=\"pii\">S0006-291X(17)30308-X</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbrc.2017.02.040</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 28189684, 0.2174, NULL, '2017-11-27');
INSERT INTO `document_caches` VALUES (28282038, 'Cell Death Differ. 2017 Jul 10. 24(7). doi: 10.1038/cdd.2017.26:1142-1147', 'The assembly of the TNFR1 signalling complex (TNF-RSC) depends on K63- and M1-linked ubiquitylation, promoting the recruitment of complex constituents and the stability of the complex. Ubiquitylation is a dynamic process, controlled by E3 ubiquitin ligases as well as deubiquitinases, such as CYLD and OTULIN. A novel molecule, SPATA2, which is crucial for recruiting and activating the deubiquitinase CYLD within the TNF-RSC, has now been identified by four different studies. Loss of SPATA2 was shown to result in increased TNF-, but also NOD2-mediated proinflammatory signalling. Importantly, SPATA2 is instrumental for TNF-induced cell death, and a closer look at these findings suggests that SPATA2 possibly has functions beyond promoting the activity of CYLD.', NULL, '2017', 'SPATA2: more than a missing link.', '2021-11-30 07:44:57', '2021-11-30 07:44:57', 'Schlicher L, Brauns-Schubert P, Schubert F, Maurer U', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">28282038</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1476-5403</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>24</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>07</Month></PubDate></JournalIssue><Title>Cell death and differentiation</Title><ISOAbbreviation>Cell Death Differ</ISOAbbreviation></Journal><ArticleTitle>SPATA2: more than a missing link.</ArticleTitle><Pagination><MedlinePgn>1142-1147</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/cdd.2017.26</ELocationID><Abstract><AbstractText>The assembly of the TNFR1 signalling complex (TNF-RSC) depends on K63- and M1-linked ubiquitylation, promoting the recruitment of complex constituents and the stability of the complex. Ubiquitylation is a dynamic process, controlled by E3 ubiquitin ligases as well as deubiquitinases, such as CYLD and OTULIN. A novel molecule, SPATA2, which is crucial for recruiting and activating the deubiquitinase CYLD within the TNF-RSC, has now been identified by four different studies. Loss of SPATA2 was shown to result in increased TNF-, but also NOD2-mediated proinflammatory signalling. Importantly, SPATA2 is instrumental for TNF-induced cell death, and a closer look at these findings suggests that SPATA2 possibly has functions beyond promoting the activity of CYLD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Schlicher</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Stefan Meier Strasse 17, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Albertstrasse 19a, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIOSS, Centre for Biological Signaling Studies, Hebelstrasse 2, Freiburg 79104, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brauns-Schubert</LastName><ForeName>Prisca</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Stefan Meier Strasse 17, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Albertstrasse 19a, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIOSS, Centre for Biological Signaling Studies, Hebelstrasse 2, Freiburg 79104, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schubert</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Stefan Meier Strasse 17, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Albertstrasse 19a, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIOSS, Centre for Biological Signaling Studies, Hebelstrasse 2, Freiburg 79104, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maurer</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><Identifier Source=\"ORCID\">0000-0002-2504-1517</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Stefan Meier Strasse 17, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Albertstrasse 19a, Freiburg 79104, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIOSS, Centre for Biological Signaling Studies, Hebelstrasse 2, Freiburg 79104, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2017</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Differ</MedlineTA><NlmUniqueID>9437445</NlmUniqueID><ISSNLinking>1350-9047</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D047888\">Receptors, Tumor Necrosis Factor, Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008954\" MajorTopicYN=\"N\">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011485\" MajorTopicYN=\"N\">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D047888\" MajorTopicYN=\"N\">Receptors, Tumor Necrosis Factor, Type I</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D054875\" MajorTopicYN=\"N\">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2016</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2017</Year><Month>02</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2017</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">28282038</ArticleId><ArticleId IdType=\"pii\">cdd201726</ArticleId><ArticleId IdType=\"doi\">10.1038/cdd.2017.26</ArticleId><ArticleId IdType=\"pmc\">PMC5520165</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mol Cell. 2013 Jun 27;50(6):818-830</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23806334</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2014 May 22;157(5):1189-202</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24813850</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Nov 15;177(10):7122-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17082629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2007 Nov;13(5):705-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17981138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):801-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Mar 20;136(6):1098-109</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19303852</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15247-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23986494</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2009 May;10(5):466-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373254</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Oct 20;64(2):251-266</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27746020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2012 Jan 20;148(1-2):213-27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22265413</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):335-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726323</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Jul 23;138(2):389-403</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19615732</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17 (10 ):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2012 Nov 1;120(18):3846-57</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22972987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Dec 26;135(7):1311-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2010 Mar 19;140(6):805-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):793-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2000 Dec;1(6):489-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11101870</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cells. 2014 Mar;19(3):254-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24461064</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 17;471(7338):368-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21368762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Mar 29;14 (12 ):2846-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26997266</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Aug 27;5:4763</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25159004</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Jul 08;8(7):e70339</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23861985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2001 Aug;21(16):5299-305</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11463813</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10 ):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2014 May 8;54(3):349-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24726327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2013 Oct;20(10 ):1381-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23892367</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2007 Jun 11;204(6):1475-85</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17548520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Jul 19;412(6844):346-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11460167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2011 Oct 30;13(12):1437-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22037414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):797-801</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 17;471(7338):363-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21368763</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1998 May 4;187(9):1477-85</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9565639</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Sep 15;63(6):990-1005</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27591049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2003 Jul 25;114(2):181-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12887920</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17 ):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Jul 21;63(2):249-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27373336</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2006 Nov;116(11):3042-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17053834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Aug 30;16(9):2271-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27545878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2013 Jun 6;153(6):1312-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23746843</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 May 16;133(4):693-703</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18485876</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Cell Res. 1999 May 1;248(2):620-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10222154</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 1998 Aug;9(2):267-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9729047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 28282038, 0.2116, NULL, '2018-11-13');
INSERT INTO `document_caches` VALUES (28701375, 'Genes Dev. 2017 Jun 1. 31(11). doi: 10.1101/gad.299776.117:1162-1176', 'Stimulation of cells with TNFα leads to the formation of the TNF-R1 signaling complex (TNF-RSC) to mediate downstream cellular fate decision. Activation of the TNF-RSC is modulated by different types of ubiquitination and may lead to cell death, including apoptosis and necroptosis, in both RIPK1-dependent and RIPK1-independent manners. Spata2 (spermatogenesis-associated 2) is an adaptor protein recruited into the TNF-RSC to modulate the interaction between the linear ubiquitin chain assembly complex (LUBAC) and the deubiquitinase CYLD (cylindromatosis). However, the mechanism by which Spata2 regulates the activation of RIPK1 is unclear. Here, we report that Spata2-deficient cells show resistance to RIPK1-dependent apoptosis and necroptosis and are also partially protected against RIPK1-independent apoptosis. Spata2 deficiency promotes M1 ubiquitination of RIPK1 to inhibit RIPK1 kinase activity. Furthermore, we provide biochemical evidence for the USP domain of CYLD and the PUB domain of the SPATA2 complex preferentially deubiquitinating the M1 ubiquitin chain in vitro. Spata2 deficiency also promotes the activation of MKK4 and JNK and cytokine production independently of RIPK1 kinase activity. Spata2 deficiency sensitizes mice to systemic inflammatory response syndrome (SIRS) induced by TNFα, which can be suppressed by RIPK1 inhibitor Nec-1s. Thus, Spata2 can regulate inflammatory response and cell death in both RIPK1-dependent and RIPK1-independent manners.', NULL, '2017', 'SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.', '2021-11-30 07:44:47', '2021-11-30 07:44:47', 'Wei R, Xu LW, Liu J, Li Y, Zhang P, Shan B, Lu X, Qian L, Wu Z, Dong K, Zhu H, Pan L, Yuan J, Pan H', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">28701375</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1549-5477</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>31</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>06</Month><Day>01</Day></PubDate></JournalIssue><Title>Genes &amp; development</Title><ISOAbbreviation>Genes Dev</ISOAbbreviation></Journal><ArticleTitle>SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.</ArticleTitle><Pagination><MedlinePgn>1162-1176</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1101/gad.299776.117</ELocationID><Abstract><AbstractText>Stimulation of cells with TNFα leads to the formation of the TNF-R1 signaling complex (TNF-RSC) to mediate downstream cellular fate decision. Activation of the TNF-RSC is modulated by different types of ubiquitination and may lead to cell death, including apoptosis and necroptosis, in both RIPK1-dependent and RIPK1-independent manners. Spata2 (spermatogenesis-associated 2) is an adaptor protein recruited into the TNF-RSC to modulate the interaction between the linear ubiquitin chain assembly complex (LUBAC) and the deubiquitinase CYLD (cylindromatosis). However, the mechanism by which Spata2 regulates the activation of RIPK1 is unclear. Here, we report that Spata2-deficient cells show resistance to RIPK1-dependent apoptosis and necroptosis and are also partially protected against RIPK1-independent apoptosis. Spata2 deficiency promotes M1 ubiquitination of RIPK1 to inhibit RIPK1 kinase activity. Furthermore, we provide biochemical evidence for the USP domain of CYLD and the PUB domain of the SPATA2 complex preferentially deubiquitinating the M1 ubiquitin chain in vitro. Spata2 deficiency also promotes the activation of MKK4 and JNK and cytokine production independently of RIPK1 kinase activity. Spata2 deficiency sensitizes mice to systemic inflammatory response syndrome (SIRS) induced by TNFα, which can be suppressed by RIPK1 inhibitor Nec-1s. Thus, Spata2 can regulate inflammatory response and cell death in both RIPK1-dependent and RIPK1-independent manners.</AbstractText><CopyrightInformation>© 2017 Wei et al.; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wei</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Lily Wen</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Science, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shan</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lu</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qian</LastName><ForeName>Lihui</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Zheming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dong</LastName><ForeName>Kangyun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Lifeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Science, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yuan</LastName><ForeName>Junying</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Heling</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201203, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 AG047231</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS082257</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType><PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2017</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genes Dev</MedlineTA><NlmUniqueID>8711660</NlmUniqueID><ISSNLinking>0890-9369</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C000624231\">Spata2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.-</RegistryNumber><NameOfSubstance UI=\"D010770\">Phosphotransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI=\"D053422\">Receptor-Interacting Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI=\"C506251\">Ripk1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType=\"ErratumIn\"><RefSource>Genes Dev. 2018 Dec 1;32(23-24):1591</RefSource><PMID Version=\"1\">30509949</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017209\" MajorTopicYN=\"N\">Apoptosis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002478\" MajorTopicYN=\"N\">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004789\" MajorTopicYN=\"N\">Enzyme Activation</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D057809\" MajorTopicYN=\"N\">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008810\" MajorTopicYN=\"N\">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018345\" MajorTopicYN=\"N\">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010770\" MajorTopicYN=\"N\">Phosphotransferases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D053422\" MajorTopicYN=\"N\">Receptor-Interacting Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018746\" MajorTopicYN=\"N\">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI=\"Q000201\" MajorTopicYN=\"N\">enzymology</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D054875\" MajorTopicYN=\"N\">Ubiquitination</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"Y\">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">CYLD</Keyword><Keyword MajorTopicYN=\"Y\">RIPK1</Keyword><Keyword MajorTopicYN=\"Y\">Spata2</Keyword><Keyword MajorTopicYN=\"Y\">necroptosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2017</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2017</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">28701375</ArticleId><ArticleId IdType=\"pii\">gad.299776.117</ArticleId><ArticleId IdType=\"doi\">10.1101/gad.299776.117</ArticleId><ArticleId IdType=\"pmc\">PMC5538438</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Immunol. 2014 Jun 15;192(12):5476-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24821972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Dis. 2015 Jun 25;6:e1800</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26111062</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2013 Nov;14(11):727-36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24129419</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2009 May;10(5):466-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373254</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Dec 11;36(5):831-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20005846</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17 (10 ):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Dec 26;135(7):1311-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1985 Dec 19-1986 Jan 1;318(6047):667-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">4079980</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2011 Nov 23;31(47):16969-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22114267</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2010 Dec 15;29(24):4198-209</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21113135</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2011 Nov;244(1):9-28</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22017428</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Dec 15;13(10 ):2258-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26670046</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):637-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455181</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2008 Nov 15;68(22):9384-93</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19010913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2017 Jan;24(1):26-37</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27518435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2008 Aug 22;134(4):668-78</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18724939</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 2007 Mar 6;17(5):418-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17306544</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2006 Oct 18;25(20):4877-87</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17006537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2011 Oct 30;13(12):1437-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22037414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Mar 21;416(6878):345-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11907583</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2015 Oct 1;60(1):63-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26344099</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2014 Aug 15;193(4):1539-1543</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25015821</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Jan 23;136(2):249-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19167327</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2005 Nov 3;48(22):6779-82</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16250635</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2012 May 4;418(3-4):134-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22227388</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2011 Dec 23;35(6):908-18</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22195746</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Sep 15;63(6):990-1005</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27591049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2008 May;4(5):313-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18408713</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17 ):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2015 Mar;22(3):222-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25686088</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Aug 30;16(9):2271-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27545878</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 2005;399:21-36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16338346</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2015 Mar 24;10(11):1836-49</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25801023</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2012 Jul 20;150(2):339-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22817896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1994 Dec 22-29;372(6508):798-800</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7997270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2014 Nov;21(11):1667-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25146924</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 1999 Feb;19(2):1569-81</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9891090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Dis. 2016 Nov 10;7(11):e2462</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27831558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 31;471(7340):591-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21455173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 28701375, 0.3881, NULL, '2018-11-13');
INSERT INTO `document_caches` VALUES (30509949, 'Genes Dev. 2018 Dec 1. 32(23-24). doi: 10.1101/gad.321075.118:1591', '', NULL, '2018', 'Corrigendum: SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.', '2021-11-30 07:45:07', '2021-11-30 07:45:07', 'Wei R, Xu LW, Liu J, Li Y, Zhang P, Shan B, Lu X, Qian L, Wu Z, Dong K, Zhu H, Pan L, Yuan J, Pan H', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">30509949</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1549-5477</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>32</Volume><Issue>23-24</Issue><PubDate><Year>2018</Year><Month>12</Month><Day>01</Day></PubDate></JournalIssue><Title>Genes &amp; development</Title><ISOAbbreviation>Genes Dev</ISOAbbreviation></Journal><ArticleTitle>Corrigendum: SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.</ArticleTitle><Pagination><MedlinePgn>1591</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1101/gad.321075.118</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wei</LastName><ForeName>Ran</ForeName><Initials>R</Initials></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Lily Wen</ForeName><Initials>LW</Initials></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Jianping</ForeName><Initials>J</Initials></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Pei</ForeName><Initials>P</Initials></Author><Author ValidYN=\"Y\"><LastName>Shan</LastName><ForeName>Bing</ForeName><Initials>B</Initials></Author><Author ValidYN=\"Y\"><LastName>Lu</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials></Author><Author ValidYN=\"Y\"><LastName>Qian</LastName><ForeName>Lihui</ForeName><Initials>L</Initials></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Zheming</ForeName><Initials>Z</Initials></Author><Author ValidYN=\"Y\"><LastName>Dong</LastName><ForeName>Kangyun</ForeName><Initials>K</Initials></Author><Author ValidYN=\"Y\"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Lifeng</ForeName><Initials>L</Initials></Author><Author ValidYN=\"Y\"><LastName>Yuan</LastName><ForeName>Junying</ForeName><Initials>J</Initials></Author><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Heling</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016425\">Published Erratum</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genes Dev</MedlineTA><NlmUniqueID>8711660</NlmUniqueID><ISSNLinking>0890-9369</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType=\"ErratumFor\"><RefSource>Genes Dev. 2017 Jun 1;31(11):1162-1176</RefSource><PMID Version=\"1\">28701375</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"entrez\"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">30509949</ArticleId><ArticleId IdType=\"pii\">32/23-24/1591</ArticleId><ArticleId IdType=\"doi\">10.1101/gad.321075.118</ArticleId><ArticleId IdType=\"pmc\">PMC6295160</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 30509949, -0.1389, NULL, '2019-11-20');
INSERT INTO `document_caches` VALUES (30697874, 'Cancer Sci. 2019 Mar 16. 110(3). doi: 10.1111/cas.13955:1117-1126', 'Inflammation plays a crucial role in the pathogenesis of cancer with tumor necrosis factor-α (TNF-α) as a key mediator. Recently, spermatogenesis-associated protein 2 (SPATA2) was identified as a TNF receptor modulator which is required for TNF-induced inflammation and apoptosis. The available data on TNF-α in ovarian cancer (OC) are inconsistent, and SPATA2 is completely uncharacterized in tumorigenesis. We analyzed expression of SPATA2 and TNFA by quantitative real-time polymerase chain reaction in tissues of 171 patients with low-grade serous (LGSOC), high-grade serous (HGSOC), endometrioid and clear cell OC compared with 28 non-malignant control tissues. We stimulated OC cells (OVCAR3) with pro-inflammatory (TNF-α, interleukin [IL]-1β) and mitogenic stimuli (IL-6, lysophosphatidic acid) to establish a direct effect between inflammatory signaling and SPATA2. Pro-inflammatory, but not mitogenic stimuli, potently induced SPATA2 expression in OC cells. Expression of TNFA and SPATA2 was higher in OC compared with control tissues (P = 0.010 and P = 0.001, respectively) and correlated with each other (P = 0.034, rs  = 0.198). When compared with grade 1 cancers, SPATA2 was expressed higher in grade 2 and 3 tumors (P = 0.011) as well as in HGSOC compared with LGSOC (P = 0.024). Multivariate survival analyses revealed that OC with high SPATA2 expression were associated with reduced progression-free survival (P = 0.048) and overall survival (P < 0.001). In conclusion, SPATA2 expression is regulated by TNF-α and IL-1β and is found to independently affect clinical outcome in OC patients. These data implicate a role of SPATA2 in tumorigenesis which warrants further investigation in gynecological malignancies.', NULL, '2019', 'Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.', '2021-11-30 07:45:05', '2021-11-30 07:45:05', 'Wieser V, Tsibulak I, Degasper C, Welponer H, Leitner K, Parson W, Zeimet AG, Marth C, Fiegl H', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">30697874</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1349-7006</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>110</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cancer science</Title><ISOAbbreviation>Cancer Sci</ISOAbbreviation></Journal><ArticleTitle>Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.</ArticleTitle><Pagination><MedlinePgn>1117-1126</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/cas.13955</ELocationID><Abstract><AbstractText>Inflammation plays a crucial role in the pathogenesis of cancer with tumor necrosis factor-α (TNF-α) as a key mediator. Recently, spermatogenesis-associated protein 2 (SPATA2) was identified as a TNF receptor modulator which is required for TNF-induced inflammation and apoptosis. The available data on TNF-α in ovarian cancer (OC) are inconsistent, and SPATA2 is completely uncharacterized in tumorigenesis. We analyzed expression of SPATA2 and TNFA by quantitative real-time polymerase chain reaction in tissues of 171 patients with low-grade serous (LGSOC), high-grade serous (HGSOC), endometrioid and clear cell OC compared with 28 non-malignant control tissues. We stimulated OC cells (OVCAR3) with pro-inflammatory (TNF-α, interleukin [IL]-1β) and mitogenic stimuli (IL-6, lysophosphatidic acid) to establish a direct effect between inflammatory signaling and SPATA2. Pro-inflammatory, but not mitogenic stimuli, potently induced SPATA2 expression in OC cells. Expression of TNFA and SPATA2 was higher in OC compared with control tissues (P = 0.010 and P = 0.001, respectively) and correlated with each other (P = 0.034, r<sub>s </sub> = 0.198). When compared with grade 1 cancers, SPATA2 was expressed higher in grade 2 and 3 tumors (P = 0.011) as well as in HGSOC compared with LGSOC (P = 0.024). Multivariate survival analyses revealed that OC with high SPATA2 expression were associated with reduced progression-free survival (P = 0.048) and overall survival (P &lt; 0.001). In conclusion, SPATA2 expression is regulated by TNF-α and IL-1β and is found to independently affect clinical outcome in OC patients. These data implicate a role of SPATA2 in tumorigenesis which warrants further investigation in gynecological malignancies.</AbstractText><CopyrightInformation>© 2019 The Authors. Cancer Science published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wieser</LastName><ForeName>Verena</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-6121-2515</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tsibulak</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Degasper</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Welponer</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-5950-6693</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leitner</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Parson</LastName><ForeName>Walther</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Legal Medicine, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zeimet</LastName><ForeName>Alain G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marth</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fiegl</LastName><ForeName>Heidelinde</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-1236-6806</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>NM_001135773.1</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN=\"Y\"><Grant><Agency>Verein zur Krebsforschung in der Frauenheilkunde</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2019</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cancer Sci</MedlineTA><NlmUniqueID>101168776</NlmUniqueID><ISSNLinking>1347-9032</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D053583\">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018124\">Receptors, Tumor Necrosis Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C425523\">SPATA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D014409\">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D063646\" MajorTopicYN=\"N\">Carcinogenesis</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053583\" MajorTopicYN=\"N\">Interleukin-1beta</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010051\" MajorTopicYN=\"N\">Ovarian Neoplasms</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000077982\" MajorTopicYN=\"N\">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018124\" MajorTopicYN=\"N\">Receptors, Tumor Necrosis Factor</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013091\" MajorTopicYN=\"N\">Spermatogenesis</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"Y\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014409\" MajorTopicYN=\"N\">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055815\" MajorTopicYN=\"N\">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">inflammation</Keyword><Keyword MajorTopicYN=\"N\">ovarian cancer</Keyword><Keyword MajorTopicYN=\"N\">spermatogenesis-associated protein 2</Keyword><Keyword MajorTopicYN=\"N\">tumor necrosis factor-α</Keyword><Keyword MajorTopicYN=\"N\">tumorigenesis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2018</Year><Month>10</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2019</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2019</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2019</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2019</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2019</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">30697874</ArticleId><ArticleId IdType=\"doi\">10.1111/cas.13955</ArticleId><ArticleId IdType=\"pmc\">PMC6398874</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Death Differ. 2017 Jul;24(7):1142-1147</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28282038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2000 Jun;25(2):160-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10835629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gynecol Oncol. 2018 Aug;150(2):331-337</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29960709</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Pharmacol Sin. 2008 Nov;29(11):1275-88</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18954521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2003 Sep;3(9):745-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12949498</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2004 Dec 9;351(24):2519-29</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15590954</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2001 Jun;7(6):1716-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11410511</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2012;18(25):3816-27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22591418</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Clin Pathol. 2013 Oct 10;13(1):24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24106912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Cycle. 2017 Jan 2;16(1):11-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27635695</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1993 May;91(5):2194-206</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8387543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cancer Ther. 2006 Feb;5(2):382-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16505113</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Cancer Biol. 2012 Feb;22(1):33-40</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22210179</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2012 Jan 1;72(1):66-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22065722</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17(10):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1950 Jan;3(1):32-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15405679</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncol Lett. 2015 Feb;9(2):979-983</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25624918</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol. 2012 Sep;120(3):612-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res Treat. 2014 Feb;143(3):447-57</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24398777</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2012 Jan 3;106(1):189-98</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22108517</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2006 Apr;42(6):745-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16517151</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2004 Aug;4(4):314-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15251122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Aug 30;16(9):2271-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27545878</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 14;424(6950):793-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12917689</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 1996 Sep 27;68(1):34-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8895537</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1998 May;16(5):1861-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9586902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gynecol Oncol. 2014 Nov;135(2):297-304</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25158036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Sep 15;63(6):990-1005</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27591049</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):652-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18178624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Jul 24;454(7203):436-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18650914</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2007 Jan 15;67(2):585-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17234767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2010 Jan;17(1):25-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373246</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2009 Oct;119(10):3011-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19741298</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2005 Nov 15;65(22):10355-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16288025</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Dec 19-26;420(6917):860-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12490959</ArticleId></ArticleIdList></Reference><Reference><Citation>Histopathology. 2014 Mar;64(4):577-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24111856</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2001 Feb 23;104(4):487-501</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11239407</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2001 Apr 27;283(1):86-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11322771</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2016 Sep;27(9):1740-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27358381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Sci. 2019 Mar;110(3):1117-1126</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30697874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2014 Oct;15(11):e493-503</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25281468</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2009 May;9(5):361-71</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19343034</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cancer. 2011 May;2(5):563-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21901169</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1988 Mar 1;167(3):1211-27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3351436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 30697874, -0.1307, NULL, '2021-01-09');
INSERT INTO `document_caches` VALUES (30984241, 'Front Genet. 2019 Mar 26. doi: 10.3389/fgene.2019.00251:251', 'A high-density genetic linkage map is of particular importance in the fine mapping for important economic traits and whole genome assembly in aquaculture species. The channel catfish (Ictalurus punctatus), a species native to North America, is one of the most important commercial freshwater fish in the world. Outside of the United States, China has become the major producer and consumer of channel catfish after experiencing rapid development in the past three decades. In this study, based on restriction site associated DNA sequencing (RAD-seq), a high-density genetic linkage map of channel catfish was constructed by using single nucleotide polymorphisms (SNPs) in a F1 family composed of 156 offspring and their two parental individuals. A total of 4,768 SNPs were assigned to 29 linkage groups (LGs), and the length of the linkage map reached 2,480.25 centiMorgans (cM) with an average distance of 0.55 cM between loci. Based on this genetic linkage map, 223 genomic scaffolds were anchored to the 29 LGs of channel catfish, and a total length of 704.66 Mb was assembled. Quantitative trait locus (QTL) mapping and genome-wide association analysis identified 10 QTLs of sex-related and six QTLs of growth-related traits at LG17 and LG28, respectively. Candidate genes associated with sex dimorphism, including spata2, spata5, sf3, zbtb38, and fox, were identified within QTL intervals on the LG17. A sex-linked marker with simple sequence repeats (SSR) in zbtb38 gene of the LG17 was validated for practical verification of sex in the channel catfish. Thus, the LG17 was considered as a sex-related LG. Potential growth-related genes were also identified, including important regulators such as megf9, npffr1, and gas1. In a word, we constructed the high-density genetic linkage map and developed the sex-linked marker in channel catfish, which are important genetic resources for future marker-assisted selection (MAS) of this economically important teleost.', NULL, '2019', 'Construction of a High-Density Linkage Map and QTL Fine Mapping for Growth- and Sex-Related Traits in Channel Catfish (Ictalurus punctatus).', '2021-11-30 07:45:12', '2021-11-30 07:45:12', 'Zhang S, Zhang X, Chen X, Xu T, Wang M, Qin Q, Zhong L, Jiang H, Zhu X, Liu H, Shao J, Zhu Z, Shi Q, Bian W, You X', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">30984241</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">1664-8021</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>10</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>Construction of a High-Density Linkage Map and QTL Fine Mapping for Growth- and Sex-Related Traits in Channel Catfish (<i>Ictalurus punctatus</i>).</ArticleTitle><Pagination><MedlinePgn>251</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fgene.2019.00251</ELocationID><Abstract><AbstractText>A high-density genetic linkage map is of particular importance in the fine mapping for important economic traits and whole genome assembly in aquaculture species. The channel catfish (<i>Ictalurus punctatus</i>), a species native to North America, is one of the most important commercial freshwater fish in the world. Outside of the United States, China has become the major producer and consumer of channel catfish after experiencing rapid development in the past three decades. In this study, based on restriction site associated DNA sequencing (RAD-seq), a high-density genetic linkage map of channel catfish was constructed by using single nucleotide polymorphisms (SNPs) in a F<sub>1</sub> family composed of 156 offspring and their two parental individuals. A total of 4,768 SNPs were assigned to 29 linkage groups (LGs), and the length of the linkage map reached 2,480.25 centiMorgans (cM) with an average distance of 0.55 cM between loci. Based on this genetic linkage map, 223 genomic scaffolds were anchored to the 29 LGs of channel catfish, and a total length of 704.66 Mb was assembled. Quantitative trait locus (QTL) mapping and genome-wide association analysis identified 10 QTLs of sex-related and six QTLs of growth-related traits at LG17 and LG28, respectively. Candidate genes associated with sex dimorphism, including <i>spata2, spata5, sf3, zbtb38</i>, and <i>fox</i>, were identified within QTL intervals on the LG17. A sex-linked marker with simple sequence repeats (SSR) in <i>zbtb38</i> gene of the LG17 was validated for practical verification of sex in the channel catfish. Thus, the LG17 was considered as a sex-related LG. Potential growth-related genes were also identified, including important regulators such as <i>megf9, npffr1</i>, and <i>gas1</i>. In a word, we constructed the high-density genetic linkage map and developed the sex-linked marker in channel catfish, which are important genetic resources for future marker-assisted selection (MAS) of this economically important teleost.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Shiyong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Xinhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shenzhen Key Lab of Marine Genomics, Guangdong Provincial Key Lab of Molecular Breeding in Marine Economic Animals, BGI Academy of Marine Sciences, BGI Marine, Beijing Genomics Institute, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Tengfei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Shenzhen Key Lab of Marine Genomics, Guangdong Provincial Key Lab of Molecular Breeding in Marine Economic Animals, BGI Academy of Marine Sciences, BGI Marine, Beijing Genomics Institute, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Minghua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qin</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhong</LastName><ForeName>Liqiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jiang</LastName><ForeName>Hucheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhu</LastName><ForeName>Xiaohua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shao</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhu</LastName><ForeName>Zhifei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>BGI-Zhenjiang Institute of Hydrobiology, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shi</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Lab of Marine Genomics, Guangdong Provincial Key Lab of Molecular Breeding in Marine Economic Animals, BGI Academy of Marine Sciences, BGI Marine, Beijing Genomics Institute, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bian</LastName><ForeName>Wenji</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Genetic Breeding Center of Channel Catfish, Freshwater Fisheries Research Institute of Jiangsu Province, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>You</LastName><ForeName>Xinxin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Lab of Marine Genomics, Guangdong Provincial Key Lab of Molecular Breeding in Marine Economic Animals, BGI Academy of Marine Sciences, BGI Marine, Beijing Genomics Institute, Shenzhen, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2019</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">channel catfish</Keyword><Keyword MajorTopicYN=\"N\">growth-related genes</Keyword><Keyword MajorTopicYN=\"N\">linkage map</Keyword><Keyword MajorTopicYN=\"N\">quantitative trait locus (QTL)</Keyword><Keyword MajorTopicYN=\"N\">sex-related marker</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2018</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2019</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">30984241</ArticleId><ArticleId IdType=\"doi\">10.3389/fgene.2019.00251</ArticleId><ArticleId IdType=\"pmc\">PMC6448050</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Rev Genet. 2001 Mar;2(3):207-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11256072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Genomics. 2001 Mar;265(1):23-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11370869</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2001 Jun;158(2):727-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11404336</ArticleId></ArticleIdList></Reference><Reference><Citation>Development. 2002 May;129(10):2419-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11973274</ArticleId></ArticleIdList></Reference><Reference><Citation>Anim Genet. 2003 Oct;34(5):379-83</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14510676</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2003 Oct;165(2):687-94</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14573480</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2004;5(2):R12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14759262</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1992 Aug 21;70(4):595-607</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1505026</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Physiol. 2004 May;89(3):229-35</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15123557</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Genomics. 2004 Sep;272(2):162-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15449174</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endocrinol. 2007 Jan;192(1):3-15</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17210738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 May 15;23(10):1289-91</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17379693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Reprod Dev. 2007 Nov;74(11):1446-55</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17440973</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2007 Nov 19;8:424</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18021442</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008;3(10):e3376</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18852878</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2009 Apr;181(4):1649-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19171943</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Biol Sci. 2009 Jun 22;276(1665):2195-208</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19324769</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2009 Jun;19(6):1124-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19420381</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Aug 1;25(15):1966-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19497933</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2009 Sep;19(9):1639-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19541911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 Aug;10(8):565-77</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19584810</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2009 Sep;7(9):e1000196</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19753101</ArticleId></ArticleIdList></Reference><Reference><Citation>Comp Biochem Physiol Part D Genomics Proteomics. 2011 Mar;6(1):11-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20430707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Biotechnol (NY). 2011 Jun;13(3):376-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20886255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Biotechnol (NY). 2011 Jun;13(3):557-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20953654</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Jan 31;6(1):e16599</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21304996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Biotechnol (NY). 2012 Feb;14(1):120-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21735350</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2011 Dec;18(6):471-82</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22086998</ArticleId></ArticleIdList></Reference><Reference><Citation>G3 (Bethesda). 2012 Jan;2(1):35-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22384380</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(2):e32253</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22389690</ArticleId></ArticleIdList></Reference><Reference><Citation>Anim Genet. 2012 Aug;43(4):476-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22497362</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2012 Aug 24;13:420</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22916800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Biotechnol (NY). 2013 Jun;15(3):321-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23053056</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(12):e52097</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23284884</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2013 Jan 28;14:58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23356773</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e58700</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23527008</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Jul 11;8(7):e68389</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23874606</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Jul 12;8(7):e68452</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23874634</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2013 Aug 20;14:566</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23957753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Dec 15;29(24):3128-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24078685</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2014 Feb;21(1):85-101</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24107803</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2013 Dec 01;14:113</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24289265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1989 Mar 10;56(5):765-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2493989</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2014 Sep 29;5:340</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25324858</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Biotechnol (NY). 2015 Apr;17(2):190-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25403497</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2015 Feb;22(1):39-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25428894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci China Life Sci. 2015 Feb;58(2):124-36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25563981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci China Life Sci. 2015 Feb;58(2):178-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25614028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Genomics. 2015 Aug;290(4):1313-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25627158</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2015 Apr;22(2):161-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25762582</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 16;10(3):e0120410</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25775256</ArticleId></ArticleIdList></Reference><Reference><Citation>Heredity (Edinb). 2015 Sep;115(3):206-15</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25873149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Sep 14;5:14057</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26365677</ArticleId></ArticleIdList></Reference><Reference><Citation>Genom Data. 2015 Dec 1;6:74-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26366374</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2015 Oct;22(5):367-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26370666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Oct 27;5:15612</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26503227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Nov 10;5:16358</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26553309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Dec 22;5:18661</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26689832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 May 26;6:26693</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27225429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Jun 02;7:11757</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27249958</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2016 Aug 22;5(1):39</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27549802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jan 12;7:40347</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28079141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Apr 19;7:46509</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28422147</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2017 Jun 6;18(1):446</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28587594</ArticleId></ArticleIdList></Reference><Reference><Citation>Reprod Fertil Dev. 2017 Sep 26;:null</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28945985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2018 Jan 1;7(1):1-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29220494</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Dec 19;9(1):1210-1228</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29416688</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2018 Apr 2;19(1):230</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29609551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 30984241, -0.4083, NULL, '2020-09-29');
INSERT INTO `document_caches` VALUES (31762063, 'EMBO J. 2020 Jan 15. 39(2). doi: 10.15252/embj.2019102201:e102201', 'The innate immune sensor NLRP3 assembles an inflammasome complex with NEK7 and ASC to activate caspase-1 and drive the maturation of proinflammatory cytokines IL-1β and IL-18. NLRP3 inflammasome activity must be tightly controlled, as its over-activation is involved in the pathogenesis of inflammatory diseases. Here, we show that NLRP3 inflammasome activation is suppressed by a centrosomal protein Spata2. Spata2 deficiency enhances NLRP3 inflammasome activity both in the macrophages and in an animal model of peritonitis. Mechanistically, Spata2 recruits the deubiquitinase CYLD to the centrosome for deubiquitination of polo-like kinase 4 (PLK4), the master regulator of centrosome duplication. Deubiquitination of PLK4 facilitates its binding to and phosphorylation of NEK7 at Ser204. NEK7 phosphorylation in turn attenuates NEK7 and NLRP3 interaction, which is required for NLRP3 inflammasome activation. Pharmacological or shRNA-mediated inhibition of PLK4, or mutation of the NEK7 Ser204 phosphorylation site, augments NEK7 interaction with NLRP3 and causes increased NLRP3 inflammasome activation. Our study unravels a novel centrosomal regulatory pathway of inflammasome activation and may provide new therapeutic targets for the treatment of NLRP3-associated inflammatory diseases.', NULL, '2020', 'PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.', '2021-11-30 07:44:44', '2021-11-30 07:44:44', 'Yang XD, Li W, Zhang S, Wu D, Jiang X, Tan R, Niu X, Wang Q, Wu X, Liu Z, Chen LF, Qin J, Su B', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">31762063</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1460-2075</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>01</Month><Day>15</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.</ArticleTitle><Pagination><MedlinePgn>e102201</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.15252/embj.2019102201</ELocationID><Abstract><AbstractText>The innate immune sensor NLRP3 assembles an inflammasome complex with NEK7 and ASC to activate caspase-1 and drive the maturation of proinflammatory cytokines IL-1β and IL-18. NLRP3 inflammasome activity must be tightly controlled, as its over-activation is involved in the pathogenesis of inflammatory diseases. Here, we show that NLRP3 inflammasome activation is suppressed by a centrosomal protein Spata2. Spata2 deficiency enhances NLRP3 inflammasome activity both in the macrophages and in an animal model of peritonitis. Mechanistically, Spata2 recruits the deubiquitinase CYLD to the centrosome for deubiquitination of polo-like kinase 4 (PLK4), the master regulator of centrosome duplication. Deubiquitination of PLK4 facilitates its binding to and phosphorylation of NEK7 at Ser204. NEK7 phosphorylation in turn attenuates NEK7 and NLRP3 interaction, which is required for NLRP3 inflammasome activation. Pharmacological or shRNA-mediated inhibition of PLK4, or mutation of the NEK7 Ser204 phosphorylation site, augments NEK7 interaction with NLRP3 and causes increased NLRP3 inflammasome activation. Our study unravels a novel centrosomal regulatory pathway of inflammasome activation and may provide new therapeutic targets for the treatment of NLRP3-associated inflammatory diseases.</AbstractText><CopyrightInformation>© 2019 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials><Identifier Source=\"ORCID\">0000-0001-6895-0713</Identifier><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Wenguo</ForeName><Initials>W</Initials><Identifier Source=\"ORCID\">0000-0001-7072-0968</Identifier><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Shuangyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jiang</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tan</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Niu</LastName><ForeName>Xiaoyin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Qijun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Zhiduo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Lin-Feng</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qin</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Su</LastName><ForeName>Bing</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0003-0871-7666</Identifier><AffiliationInfo><Affiliation>Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China§.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale University Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>31770818</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>31570770</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>81430033</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>31470845</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>13JC1404700</GrantID><Agency>The Shangai Science and Technology Commission</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2019</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D058847\">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000071199\">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C492716\">Nlrp3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011506\">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C000624231\">Spata2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI=\"C088051\">Plk4 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI=\"D000072379\">NIMA-Related Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI=\"C512686\">Nek7 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI=\"D017346\">Protein-Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"C511601\">CYLD protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI=\"D000074749\">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018385\" MajorTopicYN=\"N\">Centrosome</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000074749\" MajorTopicYN=\"N\">Deubiquitinating Enzyme CYLD</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"N\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D058847\" MajorTopicYN=\"N\">Inflammasomes</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008264\" MajorTopicYN=\"N\">Macrophages</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008810\" MajorTopicYN=\"N\">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018345\" MajorTopicYN=\"N\">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000072379\" MajorTopicYN=\"N\">NIMA-Related Kinases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000071199\" MajorTopicYN=\"N\">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010538\" MajorTopicYN=\"N\">Peritonitis</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010766\" MajorTopicYN=\"N\">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017346\" MajorTopicYN=\"N\">Protein-Serine-Threonine Kinases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011506\" MajorTopicYN=\"N\">Proteins</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"Y\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D054875\" MajorTopicYN=\"N\">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">\nCYLD\n</Keyword><Keyword MajorTopicYN=\"Y\">NEK7</Keyword><Keyword MajorTopicYN=\"Y\">NLRP3</Keyword><Keyword MajorTopicYN=\"Y\">Spata2</Keyword><Keyword MajorTopicYN=\"Y\">deubiquitination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2019</Year><Month>04</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2019</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2019</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">31762063</ArticleId><ArticleId IdType=\"doi\">10.15252/embj.2019102201</ArticleId><ArticleId IdType=\"pmc\">PMC6960439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Immunol. 2006 Apr;7(4):411-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16501569</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2020 Jan 2;39(1):e101112</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2011 Feb 25;34(2):213-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21349431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Jun 28;8:15986</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28656979</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2019 Mar 15;38(6):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30787184</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2016 Sep 15;63(6):990-1005</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27591049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2014 Mar 13;156(6):1193-1206</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24630722</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2016 Jan 1;291(1):103-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26553871</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2015 Jan 20;42(1):55-67</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25607459</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2005 May;25(10):3886-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15870263</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jun 5;348(6239):1155-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25931445</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2014 Feb 1;189(3):282-91</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24456467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Mar 29;14(12):2846-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26997266</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Sci. 2011 Nov 15;124(Pt 22):3760-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22100915</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2016 Oct;17(10):1485-1497</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2017 Mar 2;65(5):818-831.e5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28216227</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2010 Mar 19;140(6):821-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20303873</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2019 Jun;570(7761):338-343</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31189953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Dec;564(7734):71-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30487600</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 2016;2016:3481371</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27597804</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Ther Targets. 2018 Jan;22(1):59-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29171762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2011 Nov 11;147(4):853-67</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22078882</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2012 Mar;246(1):107-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22435550</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2017 Jul;24(7):1172-1183</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28362430</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Aug 7;512(7512):69-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25043000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2007 Sep;14(9):1590-604</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17599095</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Protein Sci. 2013 Nov 05;74:19.23.1-19.23.14</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24510646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Aug 30;16(9):2271-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27545878</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1997 Dec;112(6 Suppl):321S-329S</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9400897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2013 Jan 24;49(2):331-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23246432</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2011;29:707-35</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21219188</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2014 Nov;24(11):1342-53</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25342559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2010 Jan;17(1):25-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19373246</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Jul;21(7):677-87</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26121197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Div. 2007 Aug 29;2:25</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17727698</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2009 Nov;10(11):1250-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19798103</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2010 Dec 16;8(6):471-83</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21147462</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2016 May 23;37(4):377-386</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27219065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2016 Mar;17(3):250-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26642356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2015 Dec 3;163(6):1484-99</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26638075</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):null</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27908937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2013 Jun;13(6):397-411</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23702978</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2017 Jun 1;31(11):1162-1176</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28701375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2013 May;14(5):454-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23502856</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2016 Sep 1;35(17):1868-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27307491</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2010 Jan 6;29(1):131-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19893491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2016 Jul;16(7):407-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27291964</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Feb 18;530(7590):354-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26814970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>', 31762063, 0.5281, NULL, '2021-01-15');
INSERT INTO `document_caches` VALUES (33896728, 'Clin Lung Cancer. 2021 Nov 27. 22(6). pii: S1525-7304(21)00070-X. doi: 10.1016/j.cllc.2021.03.016:e795-e798', '', NULL, '2021', 'Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.', '2021-11-30 07:35:06', '2021-11-30 07:35:06', 'Bülau JE, Kreipe HH, Jessen E, von Hardenberg S, Auber B, Grohé C, Leo F', '<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n<PubmedArticleSet><PubmedArticle><MedlineCitation Status=\"In-Process\" Owner=\"NLM\"><PMID Version=\"1\">33896728</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1938-0690</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>22</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>11</Month></PubDate></JournalIssue><Title>Clinical lung cancer</Title><ISOAbbreviation>Clin Lung Cancer</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.</ArticleTitle><Pagination><MedlinePgn>e795-e798</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1525-7304(21)00070-X</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.cllc.2021.03.016</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Bülau</LastName><ForeName>Judith E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, ELK Thorax Center, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kreipe</LastName><ForeName>Hans-Heinrich</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Institute of Pathology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jessen</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Human Genetics, Laboratory Dr. Fenner &amp; Kollegen, MVZ, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>von Hardenberg</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Auber</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grohé</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, ELK Thorax Center, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leo</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, ELK Thorax Center, Berlin, Germany. Electronic address: fabian.leo@jsd.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D002363\">Case Reports</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Lung Cancer</MedlineTA><NlmUniqueID>100893225</NlmUniqueID><ISSNLinking>1525-7304</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2020</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>03</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>03</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2021</Year><Month>4</Month><Day>26</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">33896728</ArticleId><ArticleId IdType=\"pii\">S1525-7304(21)00070-X</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cllc.2021.03.016</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>', 33896728, -0.263, NULL, '2021-11-22');
COMMIT;

-- ----------------------------
-- Table structure for documents
-- ----------------------------
DROP TABLE IF EXISTS `documents`;
CREATE TABLE `documents` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pmid` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `collection_id` int(11) DEFAULT NULL,
  `source` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `abstract` text COLLATE utf8_unicode_ci,
  `year` int(11) DEFAULT NULL,
  `medline` text COLLATE utf8_unicode_ci,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `title` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `au` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `annotations_count` int(11) DEFAULT '0',
  `relations_count` int(11) DEFAULT '0',
  `ppi_score` float DEFAULT NULL,
  `pub_date` date DEFAULT NULL,
  `done` tinyint(1) DEFAULT '0',
  `update_date` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `curatable` tinyint(1) DEFAULT '1',
  PRIMARY KEY (`id`),
  KEY `index_documents_on_collection_id` (`collection_id`)
) ENGINE=InnoDB AUTO_INCREMENT=7 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of documents
-- ----------------------------
BEGIN;
INSERT INTO `documents` VALUES (1, '33896728', 1, 'Clin Lung Cancer. 2021 Nov 27. 22(6). pii: S1525-7304(21)00070-X. doi: 10.1016/j.cllc.2021.03.016:e795-e798', '', 2021, 'PubMed', '2021-11-30 07:35:11', '2021-11-30 07:43:08', 'Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.', 'Bülau JE, Kreipe HH, Jessen E, von Hardenberg S, Auber B, Grohé C, Leo F', 0, 0, -0.263, NULL, 1, '2021-11-22', 1);
INSERT INTO `documents` VALUES (2, '27591049', 1, 'Mol Cell. 2016 Sep 15. 63(6). doi: 10.1016/j.molcel.2016.08.001. pii: S1097-2765(16)30415-4:990-1005', 'The linear ubiquitin chain assembly complex (LUBAC) regulates immune signaling, and its function is regulated by the deubiquitinases OTULIN and CYLD, which associate with the catalytic subunit HOIP. However, the mechanism through which CYLD interacts with HOIP is unclear. We here show that CYLD interacts with HOIP via spermatogenesis-associated protein 2 (SPATA2). SPATA2 interacts with CYLD through its non-canonical PUB domain, which binds the catalytic CYLD USP domain in a CYLD B-box-dependent manner. Significantly, SPATA2 binding activates CYLD-mediated hydrolysis of ubiquitin chains. SPATA2 also harbors a conserved PUB-interacting motif that selectively docks into the HOIP PUB domain. In cells, SPATA2 is recruited to the TNF receptor 1 signaling complex and is required for CYLD recruitment. Loss of SPATA2 increases ubiquitination of LUBAC substrates and results in enhanced NOD2 signaling. Our data reveal SPATA2 as a high-affinity binding partner of CYLD and HOIP, and a regulatory component of LUBAC-mediated NF-κB signaling.', 2016, 'PubMed', '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.', 'Elliott PR, Leske D, Hrdinka M, Bagola K, Fiil BK, McLaughlin SH, Wagstaff J, Volkmar N, Christianson JC, Kessler BM, Freund SM, Komander D, Gyrd-Hansen M', 0, 0, 0.9999, NULL, 0, '2021-03-01', 1);
INSERT INTO `documents` VALUES (3, '27458237', 1, 'EMBO Rep. 2016 Oct 25. 17(10):1485-1497', 'K63- and Met1-linked ubiquitylation are crucial posttranslational modifications for TNF receptor signaling. These non-degradative ubiquitylations are counteracted by deubiquitinases (DUBs), such as the enzyme CYLD, resulting in an appropriate signal strength, but the regulation of this process remains incompletely understood. Here, we describe an interaction partner of CYLD, SPATA2, which we identified by a mass spectrometry screen. We find that SPATA2 interacts via its PUB domain with CYLD, while a PUB interaction motif (PIM) of SPATA2 interacts with the PUB domain of the LUBAC component HOIP SPATA2 is required for the recruitment of CYLD to the TNF receptor signaling complex upon TNFR stimulation. Moreover, SPATA2 acts as an allosteric activator for the K63- and M1-deubiquitinase activity of CYLD In consequence, SPATA2 substantially attenuates TNF-induced NF-κB and MAPK signaling. Conversely, SPATA2 is required for TNF-induced complex II formation, caspase activation, and apoptosis. Thus, this study identifies SPATA2 as an important factor in the TNF signaling pathway with a substantial role for the effects mediated by the cytokine.', 2016, 'PubMed', '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.', 'Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, Maurer U', 0, 0, 0.8537, NULL, 0, '2021-01-09', 1);
INSERT INTO `documents` VALUES (4, '27545878', 1, 'Cell Rep. 2016 Aug 30. 16(9). doi: 10.1016/j.celrep.2016.07.086. pii: S2211-1247(16)31033-6:2271-80', 'Recruitment of the deubiquitinase CYLD to signaling complexes is mediated by its interaction with HOIP, the catalytically active component of the linear ubiquitin chain assembly complex (LUBAC). Here, we identify SPATA2 as a constitutive direct binding partner of HOIP that bridges the interaction between CYLD and HOIP. SPATA2 recruitment to TNFR1- and NOD2-signaling complexes is dependent on HOIP, and loss of SPATA2 abolishes CYLD recruitment. Deficiency in SPATA2 exerts limited effects on gene activation pathways but diminishes necroptosis induced by tumor necrosis factor (TNF), resembling loss of CYLD. In summary, we describe SPATA2 as a previously unrecognized factor in LUBAC-dependent signaling pathways that serves as an adaptor between HOIP and CYLD, thereby enabling recruitment of CYLD to signaling complexes.', 2016, 'PubMed', '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.', 'Kupka S, De Miguel D, Draber P, Martino L, Surinova S, Rittinger K, Walczak H', 0, 0, 0.8337, NULL, 0, '2021-01-02', 1);
INSERT INTO `documents` VALUES (5, '31762063', 1, 'EMBO J. 2020 Jan 15. 39(2). doi: 10.15252/embj.2019102201:e102201', 'The innate immune sensor NLRP3 assembles an inflammasome complex with NEK7 and ASC to activate caspase-1 and drive the maturation of proinflammatory cytokines IL-1β and IL-18. NLRP3 inflammasome activity must be tightly controlled, as its over-activation is involved in the pathogenesis of inflammatory diseases. Here, we show that NLRP3 inflammasome activation is suppressed by a centrosomal protein Spata2. Spata2 deficiency enhances NLRP3 inflammasome activity both in the macrophages and in an animal model of peritonitis. Mechanistically, Spata2 recruits the deubiquitinase CYLD to the centrosome for deubiquitination of polo-like kinase 4 (PLK4), the master regulator of centrosome duplication. Deubiquitination of PLK4 facilitates its binding to and phosphorylation of NEK7 at Ser204. NEK7 phosphorylation in turn attenuates NEK7 and NLRP3 interaction, which is required for NLRP3 inflammasome activation. Pharmacological or shRNA-mediated inhibition of PLK4, or mutation of the NEK7 Ser204 phosphorylation site, augments NEK7 interaction with NLRP3 and causes increased NLRP3 inflammasome activation. Our study unravels a novel centrosomal regulatory pathway of inflammasome activation and may provide new therapeutic targets for the treatment of NLRP3-associated inflammatory diseases.', 2020, 'PubMed', '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.', 'Yang XD, Li W, Zhang S, Wu D, Jiang X, Tan R, Niu X, Wang Q, Wu X, Liu Z, Chen LF, Qin J, Su B', 0, 0, 0.5281, NULL, 0, '2021-01-15', 1);
INSERT INTO `documents` VALUES (6, '27307491', 1, 'EMBO J. 2016 Sep 1. 35(17). doi: 10.15252/embj.201694300:1868-84', 'TNF-α is a key regulator of innate immune and proinflammatory responses. However, the composition of the TNF-α receptor-associated signaling complexes (TNF-RSC) and the architecture of the downstream signaling networks are incompletely understood. We employed quantitative mass spectrometry to demonstrate that TNF-α stimulation induces widespread protein phosphorylation and that the scope of phosphorylation expands in a temporal manner. TNF-α stimulation also induces rapid ubiquitylation of components of the TNF-RSC Temporal analysis of the TNF-RSC composition identified SPATA2 as a novel component of the TNF-RSC The predicted PUB domain in the N-terminus of SPATA2 interacts with the USP domain of CYLD, whereas the C-terminus of SPATA2 interacts with HOIP SPATA2 is required for recruitment of CYLD to the TNF-RSC Downregulation of SPATA2 augments transcriptional activation of NF-κB and inhibits TNF-α-induced necroptosis, pointing to an important function of SPATA2 in modulating the outcomes of TNF-α signaling. Taken together, our study draws a detailed map of TNF-α signaling, identifies SPATA2 as a novel component of TNF-α signaling, and provides a rich resource for further functional investigations.', 2016, 'PubMed', '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.', 'Wagner SA, Satpathy S, Beli P, Choudhary C', 0, 0, 0.4688, '2016-06-17', 0, '2021-01-09', 1);
COMMIT;

-- ----------------------------
-- Table structure for entity_types
-- ----------------------------
DROP TABLE IF EXISTS `entity_types`;
CREATE TABLE `entity_types` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `url` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `nomenclature` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `category` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `collection_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `type_properties_count` int(11) DEFAULT '0',
  `for_entity` tinyint(1) DEFAULT '1',
  `for_relation` tinyint(1) DEFAULT '1',
  PRIMARY KEY (`id`),
  KEY `index_entity_types_on_collection_id_and_name` (`collection_id`,`name`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of entity_types
-- ----------------------------
BEGIN;
INSERT INTO `entity_types` VALUES (1, 'Protein', NULL, NULL, NULL, 1, '2021-11-30 07:31:24', '2021-11-30 07:31:24', 0, 1, 0);
INSERT INTO `entity_types` VALUES (2, 'Interact', NULL, NULL, NULL, 1, '2021-11-30 07:31:24', '2021-11-30 07:31:24', 0, 0, 1);
INSERT INTO `entity_types` VALUES (3, 'Negated_Interact', NULL, NULL, NULL, 1, '2021-11-30 07:31:24', '2021-11-30 07:31:24', 0, 0, 1);
COMMIT;

-- ----------------------------
-- Table structure for entrez_genes
-- ----------------------------
DROP TABLE IF EXISTS `entrez_genes`;
CREATE TABLE `entrez_genes` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `description` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `species` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `species_priority` int(11) DEFAULT '999',
  PRIMARY KEY (`id`),
  KEY `index_entrez_genes_on_name` (`name`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of entrez_genes
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for entrez_synonyms
-- ----------------------------
DROP TABLE IF EXISTS `entrez_synonyms`;
CREATE TABLE `entrez_synonyms` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `entrez_gene_id` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_entrez_synonyms_on_entrez_gene_id` (`entrez_gene_id`),
  KEY `index_entrez_synonyms_on_name` (`name`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of entrez_synonyms
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for info_nodes
-- ----------------------------
DROP TABLE IF EXISTS `info_nodes`;
CREATE TABLE `info_nodes` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `title` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `key` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `node_type` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `collection_id` int(11) DEFAULT NULL,
  `document_id` int(11) DEFAULT NULL,
  `passage_id` int(11) DEFAULT NULL,
  `node_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_info_nodes_on_node_id` (`node_id`),
  KEY `index_info_nodes_on_passage_id` (`passage_id`),
  KEY `index_info_nodes_on_document_id` (`document_id`),
  KEY `index_info_nodes_on_collection_id` (`collection_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of info_nodes
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for locations
-- ----------------------------
DROP TABLE IF EXISTS `locations`;
CREATE TABLE `locations` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `node_id` int(11) DEFAULT NULL,
  `offset` int(11) DEFAULT NULL,
  `length` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_locations_on_node_id` (`node_id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of locations
-- ----------------------------
BEGIN;
INSERT INTO `locations` VALUES (2, 2, 310, 4, '2021-11-30 07:45:41', '2021-11-30 07:45:41');
COMMIT;

-- ----------------------------
-- Table structure for negative_documents
-- ----------------------------
DROP TABLE IF EXISTS `negative_documents`;
CREATE TABLE `negative_documents` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `collection_id` int(11) DEFAULT NULL,
  `pmid` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `index_negative_documents_on_collection_id_and_pmid` (`collection_id`,`pmid`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of negative_documents
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for nodes
-- ----------------------------
DROP TABLE IF EXISTS `nodes`;
CREATE TABLE `nodes` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `node_text` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `node_id` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `node_type` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `document_id` int(11) DEFAULT NULL,
  `passage_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `locations_count` int(11) DEFAULT '0',
  `references_count` int(11) DEFAULT '0',
  `entity_type` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `representative_name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `index_nodes_on_document_id` (`document_id`),
  KEY `index_nodes_on_passage_id` (`passage_id`),
  KEY `index_nodes_on_document_id_and_node_type` (`document_id`,`node_type`),
  KEY `index_nodes_on_passage_id_and_node_type` (`passage_id`,`node_type`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of nodes
-- ----------------------------
BEGIN;
INSERT INTO `nodes` VALUES (2, 'CYLD', 'A1', 'A', 2, 4, '2021-11-30 07:45:41', '2021-11-30 07:45:41', 1, 0, 'Protein', NULL);
COMMIT;

-- ----------------------------
-- Table structure for participants
-- ----------------------------
DROP TABLE IF EXISTS `participants`;
CREATE TABLE `participants` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `ptype` int(11) DEFAULT NULL,
  `relation_id` int(11) DEFAULT NULL,
  `annotation_id` int(11) DEFAULT NULL,
  `order_no` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `label` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `participates_in` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of participants
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for passages
-- ----------------------------
DROP TABLE IF EXISTS `passages`;
CREATE TABLE `passages` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `offset` int(11) DEFAULT NULL,
  `document_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `ptext` text COLLATE utf8_unicode_ci,
  `passage_type` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `index_passages_on_document_id` (`document_id`)
) ENGINE=InnoDB AUTO_INCREMENT=13 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of passages
-- ----------------------------
BEGIN;
INSERT INTO `passages` VALUES (1, 0, 1, '2021-11-30 07:35:11', '2021-11-30 07:35:11', 'Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma. ', 'title');
INSERT INTO `passages` VALUES (2, 119, 1, '2021-11-30 07:35:11', '2021-11-30 07:35:11', ' ', 'abstract');
INSERT INTO `passages` VALUES (3, 0, 2, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. ', 'title');
INSERT INTO `passages` VALUES (4, 74, 2, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'The linear ubiquitin chain assembly complex (LUBAC) regulates immune signaling, and its function is regulated by the deubiquitinases OTULIN and CYLD, which associate with the catalytic subunit HOIP. However, the mechanism through which CYLD interacts with HOIP is unclear. We here show that CYLD interacts with HOIP via spermatogenesis-associated protein 2 (SPATA2). SPATA2 interacts with CYLD through its non-canonical PUB domain, which binds the catalytic CYLD USP domain in a CYLD B-box-dependent manner. Significantly, SPATA2 binding activates CYLD-mediated hydrolysis of ubiquitin chains. SPATA2 also harbors a conserved PUB-interacting motif that selectively docks into the HOIP PUB domain. In cells, SPATA2 is recruited to the TNF receptor 1 signaling complex and is required for CYLD recruitment. Loss of SPATA2 increases ubiquitination of LUBAC substrates and results in enhanced NOD2 signaling. Our data reveal SPATA2 as a high-affinity binding partner of CYLD and HOIP, and a regulatory component of LUBAC-mediated NF-κB signaling. ', 'abstract');
INSERT INTO `passages` VALUES (5, 0, 3, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death. ', 'title');
INSERT INTO `passages` VALUES (6, 88, 3, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'K63- and Met1-linked ubiquitylation are crucial posttranslational modifications for TNF receptor signaling. These non-degradative ubiquitylations are counteracted by deubiquitinases (DUBs), such as the enzyme CYLD, resulting in an appropriate signal strength, but the regulation of this process remains incompletely understood. Here, we describe an interaction partner of CYLD, SPATA2, which we identified by a mass spectrometry screen. We find that SPATA2 interacts via its PUB domain with CYLD, while a PUB interaction motif (PIM) of SPATA2 interacts with the PUB domain of the LUBAC component HOIP SPATA2 is required for the recruitment of CYLD to the TNF receptor signaling complex upon TNFR stimulation. Moreover, SPATA2 acts as an allosteric activator for the K63- and M1-deubiquitinase activity of CYLD In consequence, SPATA2 substantially attenuates TNF-induced NF-κB and MAPK signaling. Conversely, SPATA2 is required for TNF-induced complex II formation, caspase activation, and apoptosis. Thus, this study identifies SPATA2 as an important factor in the TNF signaling pathway with a substantial role for the effects mediated by the cytokine. ', 'abstract');
INSERT INTO `passages` VALUES (7, 0, 4, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. ', 'title');
INSERT INTO `passages` VALUES (8, 89, 4, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'Recruitment of the deubiquitinase CYLD to signaling complexes is mediated by its interaction with HOIP, the catalytically active component of the linear ubiquitin chain assembly complex (LUBAC). Here, we identify SPATA2 as a constitutive direct binding partner of HOIP that bridges the interaction between CYLD and HOIP. SPATA2 recruitment to TNFR1- and NOD2-signaling complexes is dependent on HOIP, and loss of SPATA2 abolishes CYLD recruitment. Deficiency in SPATA2 exerts limited effects on gene activation pathways but diminishes necroptosis induced by tumor necrosis factor (TNF), resembling loss of CYLD. In summary, we describe SPATA2 as a previously unrecognized factor in LUBAC-dependent signaling pathways that serves as an adaptor between HOIP and CYLD, thereby enabling recruitment of CYLD to signaling complexes. ', 'abstract');
INSERT INTO `passages` VALUES (9, 0, 5, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome. ', 'title');
INSERT INTO `passages` VALUES (10, 111, 5, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'The innate immune sensor NLRP3 assembles an inflammasome complex with NEK7 and ASC to activate caspase-1 and drive the maturation of proinflammatory cytokines IL-1β and IL-18. NLRP3 inflammasome activity must be tightly controlled, as its over-activation is involved in the pathogenesis of inflammatory diseases. Here, we show that NLRP3 inflammasome activation is suppressed by a centrosomal protein Spata2. Spata2 deficiency enhances NLRP3 inflammasome activity both in the macrophages and in an animal model of peritonitis. Mechanistically, Spata2 recruits the deubiquitinase CYLD to the centrosome for deubiquitination of polo-like kinase 4 (PLK4), the master regulator of centrosome duplication. Deubiquitination of PLK4 facilitates its binding to and phosphorylation of NEK7 at Ser204. NEK7 phosphorylation in turn attenuates NEK7 and NLRP3 interaction, which is required for NLRP3 inflammasome activation. Pharmacological or shRNA-mediated inhibition of PLK4, or mutation of the NEK7 Ser204 phosphorylation site, augments NEK7 interaction with NLRP3 and causes increased NLRP3 inflammasome activation. Our study unravels a novel centrosomal regulatory pathway of inflammasome activation and may provide new therapeutic targets for the treatment of NLRP3-associated inflammatory diseases. ', 'abstract');
INSERT INTO `passages` VALUES (11, 0, 6, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes. ', 'title');
INSERT INTO `passages` VALUES (12, 105, 6, '2021-11-30 07:45:14', '2021-11-30 07:45:14', 'TNF-α is a key regulator of innate immune and proinflammatory responses. However, the composition of the TNF-α receptor-associated signaling complexes (TNF-RSC) and the architecture of the downstream signaling networks are incompletely understood. We employed quantitative mass spectrometry to demonstrate that TNF-α stimulation induces widespread protein phosphorylation and that the scope of phosphorylation expands in a temporal manner. TNF-α stimulation also induces rapid ubiquitylation of components of the TNF-RSC Temporal analysis of the TNF-RSC composition identified SPATA2 as a novel component of the TNF-RSC The predicted PUB domain in the N-terminus of SPATA2 interacts with the USP domain of CYLD, whereas the C-terminus of SPATA2 interacts with HOIP SPATA2 is required for recruitment of CYLD to the TNF-RSC Downregulation of SPATA2 augments transcriptional activation of NF-κB and inhibits TNF-α-induced necroptosis, pointing to an important function of SPATA2 in modulating the outcomes of TNF-α signaling. Taken together, our study draws a detailed map of TNF-α signaling, identifies SPATA2 as a novel component of TNF-α signaling, and provides a rich resource for further functional investigations. ', 'abstract');
COMMIT;

-- ----------------------------
-- Table structure for pie_articles
-- ----------------------------
DROP TABLE IF EXISTS `pie_articles`;
CREATE TABLE `pie_articles` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `title` text COLLATE utf8_unicode_ci,
  `abstract` text COLLATE utf8_unicode_ci,
  `pub_year` int(11) DEFAULT NULL,
  `pub_date` date DEFAULT NULL,
  `source` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `authors` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `ppi_score` float DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of pie_articles
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for pie_entities
-- ----------------------------
DROP TABLE IF EXISTS `pie_entities`;
CREATE TABLE `pie_entities` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `pmid` int(11) DEFAULT NULL,
  `entrez_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_pie_entities_on_pmid` (`pmid`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of pie_entities
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for pie_entity_locations
-- ----------------------------
DROP TABLE IF EXISTS `pie_entity_locations`;
CREATE TABLE `pie_entity_locations` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pie_entity_id` int(11) DEFAULT NULL,
  `offset` int(11) DEFAULT NULL,
  `length` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_pie_entity_locations_on_pie_entity_id` (`pie_entity_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of pie_entity_locations
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for pubmed_pie_scores
-- ----------------------------
DROP TABLE IF EXISTS `pubmed_pie_scores`;
CREATE TABLE `pubmed_pie_scores` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pie_score` float DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of pubmed_pie_scores
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for pubmed_queries
-- ----------------------------
DROP TABLE IF EXISTS `pubmed_queries`;
CREATE TABLE `pubmed_queries` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `term` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `count` int(11) DEFAULT '0',
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `date_range` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `index_pubmed_queries_on_term` (`term`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of pubmed_queries
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for pubmed_query_pmids
-- ----------------------------
DROP TABLE IF EXISTS `pubmed_query_pmids`;
CREATE TABLE `pubmed_query_pmids` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pmid` int(11) DEFAULT NULL,
  `pie_score` float DEFAULT NULL,
  `pubmed_order` int(11) DEFAULT NULL,
  `pubmed_query_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_pubmed_query_pmids_on_pubmed_query_id` (`pubmed_query_id`),
  KEY `index_pubmed_query_pmids_on_pubmed_query_id_and_pubmed_order` (`pubmed_query_id`,`pubmed_order`),
  KEY `index_pubmed_query_pmids_on_pubmed_query_id_and_pie_score` (`pubmed_query_id`,`pie_score`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of pubmed_query_pmids
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for recommenders
-- ----------------------------
DROP TABLE IF EXISTS `recommenders`;
CREATE TABLE `recommenders` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `link` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `desc` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `collection_id` int(11) DEFAULT NULL,
  `type_str` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of recommenders
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for reference_labels
-- ----------------------------
DROP TABLE IF EXISTS `reference_labels`;
CREATE TABLE `reference_labels` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `label` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `reference_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of reference_labels
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for references
-- ----------------------------
DROP TABLE IF EXISTS `references`;
CREATE TABLE `references` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `ref_id` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `role` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `node_id` int(11) DEFAULT NULL,
  `order_no` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `child_id` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `index_references_on_ref_id` (`ref_id`),
  KEY `index_references_on_node_id` (`node_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of references
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for relations
-- ----------------------------
DROP TABLE IF EXISTS `relations`;
CREATE TABLE `relations` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `rtype` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `passage_id` int(11) DEFAULT NULL,
  `sentence_id` int(11) DEFAULT NULL,
  `rid` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `document_id` int(11) DEFAULT NULL,
  `entity_key` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `entity_type_id` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`),
  KEY `index_relations_on_entity_type_id` (`entity_type_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of relations
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for save_queries
-- ----------------------------
DROP TABLE IF EXISTS `save_queries`;
CREATE TABLE `save_queries` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `collection_id` int(11) DEFAULT NULL,
  `term` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `duration` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of save_queries
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for save_query_caches
-- ----------------------------
DROP TABLE IF EXISTS `save_query_caches`;
CREATE TABLE `save_query_caches` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `duration` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `save_query_id` int(11) DEFAULT NULL,
  `save_query_docs_count` int(11) DEFAULT '0',
  `cache_date` datetime DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `term` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=5 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of save_query_caches
-- ----------------------------
BEGIN;
INSERT INTO `save_query_caches` VALUES (1, '2021/11/01:2021/11/30', NULL, 0, '2021-11-30 07:33:31', '2021-11-30 07:33:29', '2021-11-30 07:33:31', 'covid');
INSERT INTO `save_query_caches` VALUES (2, '2021/11/01:2021/11/30', NULL, 0, '2021-11-30 07:44:18', '2021-11-30 07:34:15', '2021-11-30 07:44:18', 'SPATA2');
INSERT INTO `save_query_caches` VALUES (3, '2021/11/01:2021/11/30', NULL, 1, '2021-11-30 07:35:01', '2021-11-30 07:34:59', '2021-11-30 07:35:01', 'CYLD');
INSERT INTO `save_query_caches` VALUES (4, '0001/01/01:2021/11/30', NULL, 26, '2021-11-30 07:44:36', '2021-11-30 07:44:25', '2021-11-30 07:44:36', 'SPATA2');
COMMIT;

-- ----------------------------
-- Table structure for save_query_docs
-- ----------------------------
DROP TABLE IF EXISTS `save_query_docs`;
CREATE TABLE `save_query_docs` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pmid` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `score` float DEFAULT NULL,
  `save_query_cache_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `pubdate` date DEFAULT NULL,
  `update_date` date DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=28 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of save_query_docs
-- ----------------------------
BEGIN;
INSERT INTO `save_query_docs` VALUES (1, '33896728', -0.263, 3, '2021-11-30 07:35:01', '2021-11-30 07:35:01', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (2, '32301486', -0.6898, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (3, '31762063', 0.5281, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (4, '30984241', -0.4083, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (5, '30697874', -0.1307, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (6, '30570357', -0.6574, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (7, '30509949', -0.1389, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (8, '29053955', -0.4542, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (9, '29025062', -0.5041, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (10, '28701375', 0.3881, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (11, '28282038', 0.2116, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (12, '28189684', 0.2174, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (13, '27704156', -0.9999, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (14, '27635695', -0.0158, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (15, '27591049', 0.9999, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (16, '27545878', 0.8337, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (17, '27470000', -0.2069, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (18, '27458237', 0.8537, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', NULL, NULL);
INSERT INTO `save_query_docs` VALUES (19, '27307491', 0.4688, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2016-06-17', '2016-06-16');
INSERT INTO `save_query_docs` VALUES (20, '25264125', -0.0489, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2014-09-30', '2015-11-19');
INSERT INTO `save_query_docs` VALUES (21, '20119533', -0.4499, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2010-02-02', '2013-05-23');
INSERT INTO `save_query_docs` VALUES (22, '18364390', 0.0606, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2008-03-28', '2014-09-04');
INSERT INTO `save_query_docs` VALUES (23, '17486545', -0.2318, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2007-05-09', '2007-09-06');
INSERT INTO `save_query_docs` VALUES (24, '12531478', -0.4147, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2003-01-18', '2008-11-21');
INSERT INTO `save_query_docs` VALUES (25, '11322771', 0.048, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2001-04-27', '2012-02-22');
INSERT INTO `save_query_docs` VALUES (26, '11079456', -0.1968, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '2000-11-18', '2006-11-15');
INSERT INTO `save_query_docs` VALUES (27, '10222154', -0.0414, 4, '2021-11-30 07:44:36', '2021-11-30 07:44:36', '1999-05-01', '2005-11-21');
COMMIT;

-- ----------------------------
-- Table structure for schema_migrations
-- ----------------------------
DROP TABLE IF EXISTS `schema_migrations`;
CREATE TABLE `schema_migrations` (
  `version` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  UNIQUE KEY `unique_schema_migrations` (`version`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of schema_migrations
-- ----------------------------
BEGIN;
INSERT INTO `schema_migrations` VALUES ('20130211081351');
INSERT INTO `schema_migrations` VALUES ('20130309040546');
INSERT INTO `schema_migrations` VALUES ('20130309040941');
INSERT INTO `schema_migrations` VALUES ('20130309041146');
INSERT INTO `schema_migrations` VALUES ('20130309041356');
INSERT INTO `schema_migrations` VALUES ('20130309041545');
INSERT INTO `schema_migrations` VALUES ('20130309041606');
INSERT INTO `schema_migrations` VALUES ('20130309041951');
INSERT INTO `schema_migrations` VALUES ('20130309042427');
INSERT INTO `schema_migrations` VALUES ('20130330141233');
INSERT INTO `schema_migrations` VALUES ('20130330142351');
INSERT INTO `schema_migrations` VALUES ('20130403012446');
INSERT INTO `schema_migrations` VALUES ('20130404063940');
INSERT INTO `schema_migrations` VALUES ('20130404065831');
INSERT INTO `schema_migrations` VALUES ('20130404071518');
INSERT INTO `schema_migrations` VALUES ('20130404074559');
INSERT INTO `schema_migrations` VALUES ('20130404084339');
INSERT INTO `schema_migrations` VALUES ('20130410121113');
INSERT INTO `schema_migrations` VALUES ('20130410132122');
INSERT INTO `schema_migrations` VALUES ('20130410134034');
INSERT INTO `schema_migrations` VALUES ('20130425073720');
INSERT INTO `schema_migrations` VALUES ('20130425074432');
INSERT INTO `schema_migrations` VALUES ('20130425074504');
INSERT INTO `schema_migrations` VALUES ('20130426101505');
INSERT INTO `schema_migrations` VALUES ('20130428012216');
INSERT INTO `schema_migrations` VALUES ('20130428012256');
INSERT INTO `schema_migrations` VALUES ('20130506140716');
INSERT INTO `schema_migrations` VALUES ('20130524081511');
INSERT INTO `schema_migrations` VALUES ('20130524081626');
INSERT INTO `schema_migrations` VALUES ('20130525053312');
INSERT INTO `schema_migrations` VALUES ('20130525054216');
INSERT INTO `schema_migrations` VALUES ('20130525054644');
INSERT INTO `schema_migrations` VALUES ('20130526025144');
INSERT INTO `schema_migrations` VALUES ('20130526074115');
INSERT INTO `schema_migrations` VALUES ('20130530114543');
INSERT INTO `schema_migrations` VALUES ('20130530114711');
INSERT INTO `schema_migrations` VALUES ('20130530114756');
INSERT INTO `schema_migrations` VALUES ('20130602034915');
INSERT INTO `schema_migrations` VALUES ('20130602035813');
INSERT INTO `schema_migrations` VALUES ('20130602160400');
INSERT INTO `schema_migrations` VALUES ('20130602163921');
INSERT INTO `schema_migrations` VALUES ('20130602183142');
INSERT INTO `schema_migrations` VALUES ('20130602183210');
INSERT INTO `schema_migrations` VALUES ('20130604082301');
INSERT INTO `schema_migrations` VALUES ('20130604091903');
INSERT INTO `schema_migrations` VALUES ('20130605014640');
INSERT INTO `schema_migrations` VALUES ('20130605031551');
INSERT INTO `schema_migrations` VALUES ('20130605031709');
INSERT INTO `schema_migrations` VALUES ('20130606193022');
INSERT INTO `schema_migrations` VALUES ('20130606193212');
INSERT INTO `schema_migrations` VALUES ('20130606193621');
INSERT INTO `schema_migrations` VALUES ('20130606221409');
INSERT INTO `schema_migrations` VALUES ('20130802133444');
INSERT INTO `schema_migrations` VALUES ('20130803074420');
INSERT INTO `schema_migrations` VALUES ('20130803101639');
INSERT INTO `schema_migrations` VALUES ('20130803101743');
INSERT INTO `schema_migrations` VALUES ('20130804174933');
INSERT INTO `schema_migrations` VALUES ('20130805121306');
INSERT INTO `schema_migrations` VALUES ('20130805134929');
INSERT INTO `schema_migrations` VALUES ('20130806123136');
INSERT INTO `schema_migrations` VALUES ('20130807141925');
INSERT INTO `schema_migrations` VALUES ('20130807142744');
INSERT INTO `schema_migrations` VALUES ('20130807145334');
INSERT INTO `schema_migrations` VALUES ('20130820052352');
INSERT INTO `schema_migrations` VALUES ('20130825185456');
INSERT INTO `schema_migrations` VALUES ('20130830095922');
INSERT INTO `schema_migrations` VALUES ('20131108062301');
INSERT INTO `schema_migrations` VALUES ('20131116040350');
INSERT INTO `schema_migrations` VALUES ('20131116092703');
INSERT INTO `schema_migrations` VALUES ('20131123151943');
INSERT INTO `schema_migrations` VALUES ('20131126100203');
INSERT INTO `schema_migrations` VALUES ('20140105091906');
INSERT INTO `schema_migrations` VALUES ('20140105100101');
COMMIT;

-- ----------------------------
-- Table structure for sentences
-- ----------------------------
DROP TABLE IF EXISTS `sentences`;
CREATE TABLE `sentences` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `offset` int(11) DEFAULT NULL,
  `content` text COLLATE utf8_unicode_ci,
  `passage_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of sentences
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for tests
-- ----------------------------
DROP TABLE IF EXISTS `tests`;
CREATE TABLE `tests` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of tests
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for type_properties
-- ----------------------------
DROP TABLE IF EXISTS `type_properties`;
CREATE TABLE `type_properties` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `entity_type_id` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `category` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `values` text COLLATE utf8_unicode_ci,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of type_properties
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for uniprot_caches
-- ----------------------------
DROP TABLE IF EXISTS `uniprot_caches`;
CREATE TABLE `uniprot_caches` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `term` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `ret` text COLLATE utf8_unicode_ci,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_uniprot_caches_on_term` (`term`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of uniprot_caches
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for uniprot_queries
-- ----------------------------
DROP TABLE IF EXISTS `uniprot_queries`;
CREATE TABLE `uniprot_queries` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `term` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `uniprot_id` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `order_no` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_uniprot_queries_on_term` (`term`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of uniprot_queries
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for uniprots
-- ----------------------------
DROP TABLE IF EXISTS `uniprots`;
CREATE TABLE `uniprots` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `uniprot_id` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `entry_name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `protein_names` text COLLATE utf8_unicode_ci,
  `gene_name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `organism` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `length` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_uniprots_on_uniprot_id` (`uniprot_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of uniprots
-- ----------------------------
BEGIN;
COMMIT;

-- ----------------------------
-- Table structure for user_collections
-- ----------------------------
DROP TABLE IF EXISTS `user_collections`;
CREATE TABLE `user_collections` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `user_id` int(11) DEFAULT NULL,
  `collection_id` int(11) DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  PRIMARY KEY (`id`),
  KEY `index_user_collections_on_user_id` (`user_id`),
  KEY `index_user_collections_on_collection_id` (`collection_id`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of user_collections
-- ----------------------------
BEGIN;
INSERT INTO `user_collections` VALUES (1, 1, 1, '2021-11-30 07:31:24', '2021-11-30 07:31:24');
COMMIT;

-- ----------------------------
-- Table structure for users
-- ----------------------------
DROP TABLE IF EXISTS `users`;
CREATE TABLE `users` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `email` varchar(255) COLLATE utf8_unicode_ci NOT NULL DEFAULT '',
  `encrypted_password` varchar(255) COLLATE utf8_unicode_ci NOT NULL DEFAULT '',
  `reset_password_token` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `reset_password_sent_at` datetime DEFAULT NULL,
  `remember_created_at` datetime DEFAULT NULL,
  `sign_in_count` int(11) DEFAULT '0',
  `current_sign_in_at` datetime DEFAULT NULL,
  `last_sign_in_at` datetime DEFAULT NULL,
  `current_sign_in_ip` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `last_sign_in_ip` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `created_at` datetime NOT NULL,
  `updated_at` datetime NOT NULL,
  `last_name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `first_name` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `index_users_on_email` (`email`),
  UNIQUE KEY `index_users_on_reset_password_token` (`reset_password_token`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

-- ----------------------------
-- Records of users
-- ----------------------------
BEGIN;
INSERT INTO `users` VALUES (1, '38086173@qq.com', '$2a$10$8bvGuNQNHUepZo..DH8pfOxT41oMHNDZxrv/yRPVWzXjgNJBFzoMe', NULL, NULL, NULL, 1, '2021-11-30 07:29:16', '2021-11-30 07:29:16', '192.168.68.203', '192.168.68.203', '2021-11-30 07:29:16', '2021-11-30 07:29:16', '李', '占卫');
COMMIT;

SET FOREIGN_KEY_CHECKS = 1;
